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Background: Gestational diabetes mellitus (GDM) most of which progress to type 2 
diabetes mellitus (T2DM) is increasing world wide. An apprehensive increase of GDM is also 
observed in Bangladesh in line with growing prevalence of T2DM. GDM predisposes mother 
and offspring to increased risk of complication during pregnancy. Identification of GDM and 
control of glucose in pregnancy can reduce such complications and improve maternal and 
neonatal health. A standard guideline on screening of GDM is yet to be developed in 
Bangladesh.  
 
Objectives: To identify risk factors and to examine the relationship of maternal and 
neonatal complications associated with GDM in a group of hospital population. 
 
Methods: A case control study was carried out in BIRDEM and MCHTI hospital from 1st of July 
to 15th October 2004. 106 pregnant women with a diagnosis of GDM and 196 without GDM 
were included in this study. Data on risk factors and pregnancy outcomes were collected 
through a face to face interview with the mothers and checking antenatal and delivery 
records at postnatal word. 
 
Results: Maternal age >25 years, pregnancy BMI >23 kg/m2, positive family history of 
diabetes were found to be independent risk factor for GDM in multivariate analysis. Women 
who were diagnosed in the first half of the pregnancy were most likely to be treated with 
insulin [OR 3.7; 95% CI (1.6-8.9)]. Prevalence of hypertension was higher in GDM compared to 
NonGDM (12.3% vs. 4.1%). Anaemia was less prevalent in the GDM group. Preterm delivery, 
caesarean section, birth weight >3.5 kg were seen to be independently associated with GDM. 
No significant difference was found in maternal, fetal or neonatal complications either 
according to time of diagnosis of GDM or type of treatment they received. Only the 
occurrence of hypoglycemia in the neonates born to mothers with GDM has been seen to be 
higher in the women who were diagnosed early (75.8% vs. 52%) and also who received insulin 
(74.5% vs. 36.7%). Hypertension in pregnancy appeared to be significantly associated (p value 
<0.01) with the women who were diagnosed of GDM in early stage of pregnancy. Women who 
were treated with insulin had higher prevalence of birth weight more than 3.5 kg. 
 
Conclusion: This study suggests that relatively older woman; woman with a family history 
of diabetes or increased BMI possess independent risk for GDM in the study population. 
Women with GDM have increased risk of preterm birth, caesarean section and larger baby. 
GDM diagnosed early or treated with insulin in pregnancy predict higher risk of adverse 
effects in mother and newborn. Therefore, these findings should be given particular 
importance during antenatal period to initiate a screening programme and treatment 
protocol for GDM. 
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 1. Introduction 
 
Gestational diabetes mellitus (GDM) refers to any degree of glucose intolerance with 
onset or first recognition during pregnancy (1). Evidences showed that GDM poses a 
threat to adverse maternal and perinatal outcome as a result of maternal 
hyperglycemia. The United Nation’s Millennium Development Goal (MDG) targets for 
reduction of child mortality and improvement of maternal health. These are the 4th and 
5th of the 8 goals prioritized by MDG. Women with a history of GDM have a high risk of 
progression to type 2 diabetes mellitus (T2DM) (4). With the rapidly increasing 
prevalence of diabetes around the world especially in South Asian countries there is an 
urgent need to develop affordable and effective preventive strategies for T2DM. 
Identification of high risk population by identifying the risk factors and pregnancy 
outcomes of GDM can aid in the implementation of such strategies. Bangladesh has 
been ranked as 10th highest of all the countries in the world according to the number of 
diabetic population (5). Over the past few years a growing prevalence of GDM has also 
been observed in the hospitals of Bangladesh. But information is scanty on risk factors 
and pregnancy outcome. Therefore this study had focused on some aspects relevant to 
risk factors and pregnancy outcomes of GDM mothers. 
 
1.1 Country Profile 
 
Bangladesh though has made great strides in improving the lives of its people, yet 
remains as one of the poorest countries in the world (6). A brief overview of the country 
is given below: 
 
                                                   Location: Southern Asia (Table1.1a) 
Population density: 819/Sq. Km 
GDP-per capita: 2100$ (PPP) 
Literacy rate: 43.1% 
Female literacy rate: 31.8% 
Local currency: Taka (1USD eq. 65 Taka) 
Total Fertility rate: 3.13 children per woman 
Crude Birth rate: 30.1 births/1000 population 
Infant mortality: 62.6 per 1000 live births 
 
 












                                           
                                              
 
Fig. 1. 1 a). Location of Bangladesh within the world map (marked by the white squire) b). Map 
of Bangladesh and surrounding area. The area of study hospitals is marked by the black star. 
 
1.1.1 Geography 
With an area of about 144,000 sq km, Bangladesh is situated between latitudes 20°34' 
and 26°38' North and longitudes 88°01' and 92°41' East. The country is bordered by 
India on the east, west and north and by the Bay of Bengal on the south. There is also a 










Bangladesh has mostly tropical monsoon type climate with sweltering temperature and 
high humidity. It is a low-lying country situated in the middle of the Ganges delta. This 
delta landmass comprises mainly of three mighty rivers the Ganges, the Brahmaputra 
and the Meghna. Though the alluvial deposits from flood makes the soil very fertile, the 
devastation and loss from this type of catastrophe causes huge loss of life, different 
health problems and affects economy massively. 
1.1.2 Economy 
 
Bangladesh's economy depends heavily on agriculture. Textile industry and remittance 
from people abroad are also the potential sources of GDP in Bangladesh. Bangladesh 
suffers from economic difficulties and relies on foreign aid. The country’s total health 
expenditure per capita is 3.1% of GDP. A greater part of the health expenditure comes 
from out of pocket due to insufficient capacity in public sector even for basic health 
needs. 
 
1.1.3 People and culture 
 
According to the world health report 2005 total population of Bangladesh is assumed to 
be 147,360000 and population density more than 819 per sq.km. Despite better 
progress in growth rate (2.23%) it has remained as one of the most densely populated 
countries in the world. About 25% of the population lives in urban areas.  
 
Over 97.5% of its people are Bengalis; the remainders are Biharis and indigenous tribal 
peoples. Bangladeshis identify themselves closely with Bangla, their state language. 
Family and kinship was the core of social life in Bangladesh. Although the age at 
marriage appeared to be rising since the 1980s, still 80% of girls are married by 
adolescent period (56). 
 
1.1.4 Socio cultural history 
 
Bengal was probably the wealthiest part of the subcontinent until the 16th century. 
Bangladesh came to today's shape through a long history of political and cultural 
evolution. This nation was ruled by the British regime for about 200 years until 1947. 
Initially a part of Pakistan, following partition from India in 1947, Bangladesh achieved 
full independence in 1971. 
 
The present and main ethnic identity of Bangladeshi people is represented by Bengali. 
Ethnicity refers to a complex concept which has both socio-cultural and biological 
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components. Ethnic groups change through time in complex ways. Thus ethnicity bears 
a historical construct. Like Hindi, Urdu or Punjabi speaking people Bengalis are also the 
modern decedents who might be belonged to ancient Indo Aryan and Dravidian arising 
out of central and Middle East Asia. That’s why a closed ethnic similarity is found 
among them. 
 
1.1.5 Education  
 
Education in Bangladesh is mostly subsidized by the Government, which operates 
many schools and colleges in the primary, secondary and higher secondary level as 
well as many public universities and university colleges. The current literacy rate of 
Bangladesh is about 41% while female literacy rate is 30%. To promote literacy among 
women, education is now free upto the higher secondary level for female students. 
There are also government funded programs which gives incentives like stipends and 
food for continuing education to girls in the secondary level. But this has also been 
heavily criticised for nonfunctioning of the system due to hugely practised corruption in 
the country. In contrast the role of UNICEF and some NGOs working for development 
of women in Bangladesh has been greatly recognised.  
 
In Bangladesh, educational system is categorized in the following steps 
 
Primary Level ................................................. 1-5 year 
Secondary Level ........................................... 6-10 year 
Higher Secondary level ............................... 11-12 year 
Higher study 
Graduation (Pass course) ..................13-14 year 
Graduation (Honours) ........................13-15 year or more 
Post graduation ................................ 15/16 year or more 
 
 
1.1.6 Life style and physical activity 
 
Life style of people differs markedly according to rural and urban dwellings. Women in 
the rural area have to do different kind of manual works during their daily activities even 
inside the house. Cleaning of house, cooking, washing, taking care of children, 
gardening etc. all those requires good physical activities in the rural place. On the other 
hand, city people are exposed to rather easy way of daily life. But economic condition of 
the people and social status do also control the way of life of the people. Like the other 
Asians, Bangladeshi people do not have the tradition of doing extra physical exercise 
apart from the requirement for their occupation in daily life.  
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Most of the women put lots of their efforts in house hold activities being a housewife 
after marriage. However there prevails a marked difference in amount of work in 
household activities between rural and urban set up and socioeconomic status. 
1.1.7 Food habit 
Bengali food is very similar to that of the rest of the Indian subcontinent. There are more 
fish recipes in the standard diet because of the availability of fish from the rivers and 
sea. But it has been seen to be insufficient as well as expensive to meet increasing 
population load and people of varying economic status. As rice has been the main 
staple food, available in sufficient quantity and relatively cheap, people developed a 
kind of dependency on rice in almost every meal. People of this region have a tendency 
to satisfy hunger by taking bulks of rice with very minimum spicy fish or meat or 
vegetable curry. Their inherent taste for a spicy, sweet or salty food often restrains 
them to take less cooked vegetables and salad. Similar to other countries of south Asia 
sleeping after lunch and immediately after late dinner is also a very common tradition in 
Bangladesh. 
1.1.8 Trend of urbanization in Bangladesh  
Bangladesh is still an agrarian society though nearly one quarter of the population lives 
in the urban areas. A total of 50.1 million of people are involved in institutional work. 
Due to gradual urbanization relatively educated and rich people had moved in to the 
urban area. Poor people also moved towards urban area in search of work. Population 
burden and political instability pushed the country towards severe poverty tarnishing the 
history of glorious past which is once used to have food surplus. 
 
Dhaka with a total population of 9.4 million is one of the densest cities of the world. It is 
expanding very rapidly. Population of Dhaka, the capital city of Bangladesh, is 3 times 
greater than the next largest city.  According to the 2001 population census, the urban 
population in Bangladesh is 29 million, and has increased at the rate of 38% during the 
last 10 years, which is about 4 times the rural rate (MOHFW 2001). This shift may have 
a large impact on the urban health care system. Compared to demand of this huge 
population, health care facilities in Dhaka are quite inadequate. 
 
1.1.9 Overall health status in Bangladesh 
Though there has been a significant decline of infant and child morality the maternal 
death ratio is still high at over 380 per 100,000 live births (7). Apart from new and old 
infectious diseases, such as malaria, tuberculosis and acquired immune deficiency 
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syndrome (AIDS) non communicable diseases such as diabetes, hypertensions are 
important threats to health for the years ahead.  
The nutritional status of adolescent girls and women is a key factor in the persistence of 
malnutrition in Bangladesh. Low birth weight is estimated to affect 30-50 percent of 
infants (8). About 70% of the women suffer from nutritionally deficiency anemia (9). 
Bangladesh has been experiencing an epidemiological transition from communicable 
diseases to non-communicable diseases (NCD). Tertiary level hospital data indicates 
that cardiovascular diseases have already appeared as one of the leading causes of 
mortality. NCDs are important cause of disease burden, morbidity and mortality. At 
least 25% of the deaths in primary and secondary government health facilities are 
caused by these diseases. Presently, Bangladesh does not have a community based 
public health program for NCDs. Only hospital based service, although poor, is 
available (10). 
 
The Health, Nutrition, Population Sector Programme (HNPSP) has identified three 
NCDs-cancer, cardiovascular diseases and diabetes mellitus-as major public health 
problems. Looking at the surveillance finding worldwide WHO has recommended to list 
prevalence of diabetes as one of the basic health indicator for its member states (11). 
1.1.10 Health care system in Bangladesh 
Government of Bangladesh provides health care service under a health system 
infrastructure which follows local government system. Six divisions of local government 
are broken down into 64 districts, subdivided into 460 thanas, thence into unions and 
villages (Table 1). Besides the public sector, private, citizen organizations and NGOs 
(Non Governmental Organizations) also play large roles in the Bangladesh health 
sector.  
Table 1: Health care service in public sector in Bangladesh 
Level of  care Administrative 
Unit (Number) 
Health facility (Number) 
Tertiary level Division (6) Teaching hospital /Institute (16) 
Secondary level District (64) District hospital (59) 
Upazilla (460) Upazilla health complex (397) Primary level 
Union  Union Health and Family Welfare 
centers (3275) 
Out reach service Village (68000) Satellite or mobile clinic 
 
                                                                      Source: Bangladesh National Health Accounts, 1996-97 
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1.2 Diabetes Mellitus – Background 
 
Diabetes mellitus is a chronic disease caused by inherited and/or acquired deficiency in 
production of insulin by the pancreas, or by the ineffectiveness of the insulin produced 
(12). An acquired deficiency may be triggered by life style factors. However a deficiency 
of insulin results in increased concentrations of glucose in the blood, which in turn 
damage many of the body's systems, in particular the blood vessels and nerves.  








Certain genetic markers have been shown to increase the risk of developing Type 1 
diabetes. Type 2 diabetes is strongly familial, but it is only recently that some genes 
have been consistently associated with increased risk for Type 2 diabetes in certain 
populations. Both types of diabetes are complex diseases caused by mutations in more 
than one gene, as well as by environmental factors. 
1.2.1 The global burden of diabetes 
According to WHO in 2004 at least 171 million people worldwide had diabetes; this 
figure is likely to be more than double by 2030. WHO predicts 170% increase in the 
number of people with diabetes for the developing countries (8).The greatest increase 
is projected in India (195%) (13). An increasing trend of prevalence of diabetes has 
been found in the urban areas in comparison to rural areas in developing countries and 
in female population in Indian continent (8). 
 
Â  Type 1 diabetes (formerly known as insulin dependent) in which 
the pancreas fails to produce the insulin which is essential for 
survival. This form develops most frequently in children and 
adolescents, but is being increasingly noted later in life. 
Â Type 2 diabetes (formerly named non-insulin dependent) which 
results from the body's inability to respond properly to the 
action of insulin produced by the pancreas. Type 2 diabetes is 
much more common and accounts for around 90% of all 
diabetes cases worldwide. It occurs most frequently in adults, 
but is being noted increasingly in younger people as well.  
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1.2.2 Diabetes in Bangladesh 
 
Diabetes mellitus particularly type 2 diabetes is now recognized as a major chronic 
public health problem in Bangladesh. The magnitude of diabetes remains unknown due 
to lack of countrywide survey. Some studies showed that the prevalence is higher in 
urban areas (14;15).  In a recent study in Bangladesh a higher prevalence of diabetes 
was found in urban (8.1%) compared with rural populations (2.3%) (14). 
 
1.2.3 Existing diabetes health care services in Bangladesh 
 
The comprehensive diabetic health care delivery in Bangladesh is a unique program of 
Diabetes Association of Bangladesh (DAB). The Association executes its program 
primarily through its central institute called the Bangladesh Institute of Research and 
Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), and through 
the Satellite Diagnostic Clinic at different peripheral region to provide services at 
doorsteps. Now days, BIRDEM is recognized as the center of excellence and reference 
center in diabetes care. 
 
To improve the diabetic care and enlarge the service for a wide range of population, 
diabetic association has established National Healthcare Network (NHN) through out 
the country. In addition to diagnosis, the NHN centers provide out patients service free 
of cost. 
 
1.3 Gestational Diabetes Mellitus (GDM) 
 
GDM as mentioned is any form of diabetes mellitus or impaired glucose tolerance (IGT) 
or impaired fasting glucose with first onset or first recognition during the index 
pregnancy. Thus the diagnosis of GDM is independent of possibility that diabetes or 
glucose intolerance may have antedated the pregnancy. As diabetes or glucose 
intolerance in women is more frequently discovered during pregnancy WHO has 
recommended to include such cases under the definition of GDM. Such a broad 
definition has a great practical value and has boosted research on GDM. 
 
1.3.1 Glucose tolerance in Normal and GDM pregnancy 
 
Pregnancy is normally attended by progressive insulin resistance that begins near mid-
pregnancy and progresses through the third trimester. The fact that insulin resistance 
rapidly abates following delivery suggests that the major contributors to this state of 
resistance are placental hormones. Moreover pancreatic β cells normally increase their 
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insulin secretion to compensate for the insulin resistance of pregnancy. As a result, 
changes in circulating glucose levels over the course of pregnancy are quite small 
compared with the large changes in insulin sensitivity (16).  
 
From a pathophysiological point of view, GDM pregnancies are characterized by 
increased insulin resistance compared with normal pregnancies. The insulin resistance 
affects carbohydrate and lipid metabolism and presumably protein metabolism as well 
(4). Though in most of the cases it disappears once the pregnancy is over, it may 
persist as diabetes, impaired fasting plasma glucose or impaired glucose tolerance- 
after delivery or recur as such in the following pregnancy or any time after delivery. 
 















1.3.3 Effects of GDM on Maternal and child health 
 
The millennium development Goals have placed maternal and newborn’s health firmly 
on international agenda. Though gestational diabetes has not yet brought up directly in 
developing countries in maternal and newborn health; it is the fact that it threats 
pregnancy and the newborn if maternal glucose level is not controlled during the 
pregnancy. Certainly it has potential role on reducing risk of maternal health and infant 
mortality. In GDM risk of macrosomia, intrauterine death of the fetus and preeclampsia 
make the pregnancy unsafe. WHO is working on supportive funding for the 




i). Maternal hyperglycemia causes fetal outcome i.e. 
macrosomia, large for gestational age, baby, intrauterine 
death, preterm birth, birth defects etc. 
 
ii).    Association of GDM with preeclampsia, which very often 
threats mother’s life and pregnancy outcome, has been 
evident in many studies. 
 
iii).   GDM predicts subsequent development of diabetes later 
in life. The incidence of subsequent type 2 diabetes 
following gestational diabetes has been reported to be 
between 3 and 60 % in various studies. 
i). t r l r l i   f t l t  i. . 
r i , l r  f r t ti l , , i tr t ri  
t , r t r  irt , irt  f t  t . 
 
ii).    i ti  f  it  r l i , i  r  ft  
t r t  t r’  lif   r  t ,   
i t i   t i . 
 
iii).    r i t  t l t f i t  l t r 
i  lif .  i i  f t t   i t  
f ll i  t ti l i t    r rt  t   
t      i  ri  t i . 
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1.3.4 Maternal and child health situation in Bangladesh 
 
WHO launched the Making Pregnancy Safer (MPS) initiative in Bangladesh in 1999 to 
respond to global challenges of maternal and newborn health (3).Their strategy is to 
focus on evidence based intervention that target the major causes of maternal and 
newborn morbidity and mortality. The five major causes of maternal death are 
haemorrage, eclampsia, unsafe abortion, sepsis and obstructed labor (17). 
 
The goal is to reduce maternal and newborn mortality and morbidity. Maternal mortality 
ratio is aimed to be reduced by 75 percent from 1990 levels by 2015 and infant mortality 
ratio to below 35 per1000 live birth. The MPS initiative aims to save the lives of more 
than 500,000 women who die world wide every year, as a result of causes related to 
pregnancy and child birth. 
 
The key indicators related to maternal and child health in Bangladesh is presented in 
the table 2. 
 
 
Table 2: Maternal and child health in Bangladesh: Key Indicators 
 
Average age of first marriage, 2003 161
Average age at first Birth, 2003 181
Total fertility rate (TFR), 2000-2005 3.31
Maternal mortality ratio (MMR), 2000 3201
Infant mortality rate (IMR), 2000-2005 661
Anemia in pregnant women (<11mg %) 49%2
Home Delivery  90%3
Attended by trained health personnel 11.83
% of low birth weight 50%4
Woman avail  one or more antenatal care check 47.5%3
 
  Source: 
 
  1.  The Department of Family and Community health, WHO South East Asian Regional Office. 
  2.  HNPSP (PIP) 
  3.  Making Pregnancy Safer, Family and Community Health, World Health Organization, Bangladesh. 
  4.  United Nation Administrative Committee on Coordination, Sub Committee on Nutrition, Nutrition 
       Policy. Paper No.18, February’ 2000. 
 
1.3.5 Maternal and child health service in Bangladesh 
 
There has been a significant increase in use of antenatal care among pregnant women, 
from 33% in 2000 to 49% in 2004. Now, almost half of pregnant women receive at least 
one antenatal care visit from a trained health provider. Despite the rise in antenatal 
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care, only one in four women receive three or more antenatal visits during her 
pregnancy, and a vast majority of women give birth without a trained birth attendant. 
 
Component of antenatal care in public health facility in Bangladesh 
 
 Measurement of Height of pregnant women. 
 Measurement of Weight of pregnant women. 
 Physical examination for anemia and edema. 
 Blood test for Hb%. 
 Urine examination for glucose and albumin. 
 Blood Pressure measurement of the women. 
 Fundal height. 
 Fetal sound in late pregnancy. 
 Health education on pregnancy care. 
 Tetanus toxoid vaccination   
 Birth planning 
 Knowledge on danger sign of the pregnancy  
        and what to do if situation arises like these.  
In referral (secondary and tertiary hospital) 
 Random blood sugar ± 
 Ultra sonogram for pregnancy profile ± 
 
1.3.6 Screening of GDM in Bangladesh 
 
WHO and BIRDEM jointly worked for formulation of standard treatment guideline for 
diabetes. Thereby they proposed screening of diabetes in non pregnant women which 
is also applicable to pregnant women of Bangladesh. Screening for diabetes has not 
yet integrated in antenatal care component routinely in Bangladesh. Secondary and 
tertiary hospitals advise the pregnant women to do random blood glucose test. Based 
on the report they make further planning of respective pregnancies. A standard 
guideline for screening diabetic pregnancy is still non existent. Some of the private 
practitioners or specialists recommend diabetes screening routinely or if they find any 
risk factor to their patients. A guideline for screening diabetes proposed by BIRDEM is 






1.4 Statement of problem 
 
In the aftermath of increasing prevalence of type 2 diabetes in Bangladesh, it is 
reasonable to postulate that there is a growing prevalence of gestational diabetes. 
Bangladeshi women have been seen to have higher IGT than their male counterpart 
(15). Compared to the other South Asian population Bangladesh has higher birth rate 
(18) and has the prevalence of multiparty. Perinatal mortality and infant mortality is also 
high in Bangladesh (19). Though there is no published report on the prevalence of 
preeclampsia in Bangladesh the Obstetric and Gynaecological society (OGSB) in 
Bangladesh estimates 16% of maternal death from eclampsia (20). In addition, 
according to OGSB obstructed labour accounts for 8% of maternal death. Frequency of 
congenital malformations and low birth weight also appears to be higher in Bangladesh.  
 
Increased morbidity and mortality among mothers and newborns in Bangladesh may in 
part be due to the effect of GDM (2). Data on the subject is scarce resulting in a lack of 
guideline for clinical investigation for pregnant mother which is likely to bear grave 
consequence. Risk factors predisposed to GDM need to be identified in this region in 
order to initiate a selective screening during pregnancy period to ensure safe mother 
hood and identify women with risk of diabetes later in life. 
 
Studies addressing the relationship of gestational age at GDM diagnosis and 
pregnancy outcomes are scarce in Bangladesh. Evidences report that gestational 
diabetes affects pregnancy and fetus adversely if mother’s glycaemia is uncontrolled 
and has been high. Therefore the aim of treatment during the pregnancy is to keep 
mothers’ blood glucose level under normal range either by diet or by insulin. Information 
on the risk of these complications would have helped to continue or readjust the 
treatment protocol of GDM in Bangladesh. 
 
Careful search of literature provided no data on prevalence of GDM based on the time 
of diagnosis in Bangladesh perspectives. In spite of reports that claim 40-66% of 
gestational diabetes can be detected in early pregnancy there have been conflicting 
studies on the usefulness of glucose screening at early pregnancy (21). Nevertheless 
one could reasonably suggest that women with gestational diabetes in early pregnancy 
could benefit from earlier metabolic control as well as prediction of pregnancy and fetal 
complication in this group. 
 
 
A study conducted in India found different types of fetal complication at different level of 
glycaemic control. With improved glycaemic control and advanced neonatal care 
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perinatal adversities in GDM have approached that of non diabetic mothers (1;22). 
Thus intervention either by diet or by insulin in GDM may predict risk or possible 
outcome of the index pregnancy. Information on this would help to take preventive 
measures and make a birth planning in order to ensure a safer pregnancy for 
Bangladeshi women. 
 
1.5 Literature Review 
 
We conducted a detail literature search in order to elicit known and unknown facts on 
gestational diabetes relevant to our study. Specific search was also conducted on risk 
factors, ethnic distribution and fetal and maternal complication of GDM.  
 
1.5.1 Pathogenic factors for gestational diabetes 
 
From pathogenic point of view the exaggerated insulin resistance could be to some 
extent be explained by overweight or obesity which is more frequent in women with 
GDM (23). Gene mutation that is responsible for maturity onset diabetes of the young, a 
genetically and clinically heterogeneous group of autosomally dominant early onset 
type 2 diabetes with insulin secretion defects , have also been found in some women 
with GDM (20). One study in Germany found that the presence of auto antibodies 
identified a subgroup of GDM who are at risk for subsequent development of type 1 
diabetes (24). 
 
Pregnancy has commonly been viewed as a cooperative interaction between a mother 
and her fetus. The effects of natural selection on genes expressed in fetuses, however, 
may be opposed by the effects of natural selection on genes expressed in mothers. In 
this sense, a genetic conflict can be said to exist between maternal and fetal genes. 
Placental hormones are predicted to manipulate maternal physiology for fetal benefit. 
Gestational diabetes develops if the mother is unable to mount an adequate response 
to fetal manipulation (25). Thus pathogenic factors related to both type 1 and type 2 
diabetes have been characterized by women with GDM. It appears therefore that GDM 
is pathogenetically a heterogeneous syndrome.  
 
1.5.2 Prevalence of GDM  
The prevalence of GDM varies in direct proportion to the prevalence of Type 2 diabetes 
in a given population or ethnic group (26). The reported prevalence of GDM in the USA 
ranges from 1% to 14%, with 2-5% being the most common rate (27). The WHO Ad 
 25
Hoc Diabetes Reporting Group noted markedly different rates of diabetes and IGT in 
different populations, from as low as < 1% to > 10%. In some of the populations, more 
than half the cases of diabetes were undiagnosed prior to the survey. IGT was mostly 
overlooked in routine clinical practice. Thus, a substantial proportion of abnormal 
glucose tolerance in pregnancy goes undetected without screening (28). 
An especially high prevalence was detected in Zuni Indian women (14.3%), Chinese 
women (13.9%), Indian-born women (15%) in Melbourne Australia and Asian women in 
Illawarra, Australia (11.9%) (29). One WHO study (1) showed that for a given 
population and ethnicity, the risk of diabetes in pregnancy reflects the underlying 
frequency of Type 2 diabetes. 
In Bangladesh a recent study conducted in a rural community found the overall 
prevalence (95% CI) of diabetes  6.8% (1.88-9.32) and 8.2% (3.74-12.64) according to 
FBG and 2hBG, respectively (2). From hospital registry of BIRDEM hospital it has been 
seen that the number of GDM cases were registered 403 in 2001 and 412 in 2002. 
1.5.3 Diagnostic criteria proposed and used in different studies on GDM 
The ADA Expert Committee (1997) recommended a screening test performed with a 
50-g glucose load between 24 and 28 weeks of gestation. Those values were based on 
the cut off value proposed by O'Sullivan and Mahan in 1964 .But these were converted 
to plasma values by the NDDG in 1979. Discrepancies arose because of the 
interpretation of O'Sullivan and Mahan's values. Not only the substrate measured 
switched from whole venous blood to venous plasma, but also the laboratory technique 
switched from Somogyi–Nelson method to enzymatic ones. Furthermore, the NDDG 
approach based on O'Sullivan and Mahan's values were rounded differently by 
Carpenter and Coustan (1982). The Fourth Workshop recommended the use of the 
plasma glucose values proposed by Carpenter and Coustan (1). 
The recent 1999 WHO recommendations (12) indicated that women meeting either 
criteria for diabetes or impaired glucose tolerance or fasting glucose by  OGTT were 
considered to have gestational diabetes. Values for screening different glucose 
intolerance are same for pregnant and nonpregnant state (12). An oral glucose 
tolerance test (OGTT) to establish diagnostic status of glucose intolerance  need only 
be considered if random blood glucose values lie in the uncertain range (i.e. between 
the levels that establish or exclude)  and fasting glucose levels are below those which 
establish the diagnosis(30). 
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1.5.4 Risk factors for GDM 
The traditional and most often reported risk factors for GDM were high maternal age, 
weight and parity, previous delivery of a macrocosmic infant, and family history of 
diabetes. In Sweden, a population-based study revealed that advanced maternal age 
and high BMI were found to be risk factors for increased OGTT values (4). 
In USA at New York City older mothers, heavier women, those with a positive family 
history of diabetes, women with a history of infertility, and those who delivered on the 
clinic service are the high risk group for GDM. Their data suggest that, after controlling 
for traditional risk factors (maternal age, prepregnancy weight, and a family history of 
diabetes), Orientals, first generation Hispanics, women from the Indian subcontinent 
and the Middle East, those with a history of infertility, and low socioeconomic status 
women are at an increased risk for gestational diabetes (31). 
In Italian women universal screening of GDM found the rate of GDM significantly higher 
in women with a positive history of diabetes, increasing age, previous pregnancies, pre-
pregnancy overweight and short stature (32). In China, the risk of glucose intolerance in 
young women with positive family history is similar to that in the background pregnant 
population. Standard oral glucose tolerance test may not be necessary in this group of 
women if selective screening policy is adopted (33). 
A case control study conducted in Melbourne have found out that age ≥ 25 years body 
mass index ≥ 27 kg/m2, high-risk racial heritage, family history of diabetes mellitus 
carries risk for GDM. Other proposed criteria (previous GDM and glycosuria) added no 
further diagnostic power. Selective screening using the above four criteria would have 
missed two of 313 cases (0.6%) and could have saved screening up to 1,025 women 
without GDM (17% of all women). So it has been shown that selective screening for 
GDM based on prior risk assessment can reduce the need for testing with negligible 
loss of diagnostic efficiency (34). 
One study done in London found that Bengali-Asians pregnant women with GDM living 
in an east London health district were older and of higher parity than the Caucasians 
and more frequently required insulin therapy. 20% of the Bengali population 
demonstrated persisting abnormality of glucose tolerance, whereas no abnormalities 
were evident in the Caucasian group (35). 
 
A study has been done in Bangladesh to look at the nutritional status and birth 
outcomes diabetic and non diabetic pregnancies which found out that mothers age, 
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anthropometrical measurements like mean height, weight and less educational level of 
women have been higher for diabetic mothers from non diabetic mothers (36). Another 
recent study conducted in rural community in Bangladesh didn’t find any association of 
mother’s age, Height, weight, BMI with GDM (2). 
 
1.5.5 Complications of pregnancy in relation to GDM 
Nasrat et al. (Saudi Arabia) examined pregnancy outcome in 212 women with untreated 
IGT and 212 women with normal glucose tolerance, and concluded that IGT does not 
lead to any adverse outcome (37). Similar findings were reported by Ramtoola et al. 
(Mauritius), who failed to find an excess perinatal mortality in 267 pregnant women with 
IGT compared with a background population (38). 
By contrast, Moses and Calvert (Australia) suggested that the clinically optimal level for 
glycaemia during pregnancy should be as near to normal as possible. They studied the 
proportion of assisted deliveries and the proportion of infants admitted to special care in 
relation to the range of glucose tolerance, and found an association between glycaemia 
and both outcomes (39). 
Aberg et al. (Sweden) conducted a population-based study of maternal and neonatal 
characteristics and delivery complications in relation to findings for the 75-g, 2-h OGTT 
at 25-30 weeks' gestation. An increased rate of caesarean section and infant 
macrosomia was observed in the group with a glucose tolerance of 140-162 mg/dl (7.8-
9 mmol/l) and in the GDM group (4). 
Fetal outcomes examined were miscarriage <24 weeks, stillbirths, neonatal deaths up 
to 28 days of life, prenatal mortality, congenital malformations and size for gestational 
age. Maternal outcomes examined were rates of caesarean section and normal 
deliveries, and number of pre-term deliveries <37 completed weeks of gestation. 
Outcomes for Indo-Asian and Caucasian women were similar, with a take-home baby 
rate of 96% and 92% (40). 
When correcting for ethnicity more Asian than White/European GDM mothers delivered 
LGA infants. This study remarks that ethnic influences were important when defining 
LGA infants and that mild disturbance of maternal glycaemia had a greater influence on 
the birth weight of Asian than White/European infants (41). 
In a study a randomized clinical trial to determine whether treatment of women with 
gestational diabetes mellitus reduced the risk of prenatal complications .The rate of 
serious prenatal complications was significantly lower among the infants of the women 
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in the intervention group than among the infants of the women in the routine-care 
group. Women in the intervention group had a higher rate of induction of labor than the 
women in the routine-care group. Thus treatment of gestational diabetes reduces 
serious prenatal morbidity and may also improve the woman's health-related quality of 
life (42). 
 
After adjustment for BMI, age, ethnicity, parity and prenatal care, gestational diabetes 
was found to be strongly associated with different grades of pregnancy induced 
hypertension in one study in USA. Early screening and management of pregnant 
women with maternal historical risk factors is emphasized from the view of diminishing 
complications, especially the frequency of macrosomia (43). 
 
One study done in India looked at the effects of different glycaemic control on fetus. 
Even tight control of glucose caused large for gestational age newborn where as 
average control of glucose displayed better result with lower incidence of LGA. But both 
in tight control and average control of blood glucose incidence of small for gestational 
age and birth asphyxia has been higher in contrast to uncontrolled glucose. For GDM 
patients all parameters may not be uniformly affected by the same degree of glycaemic 
control. A tight control may not be the only factor to decide on the outcomes for PGDM 
patients (22). 
 
In India, Ramachandann et al. conducted a study over south Indian women and noticed 
that macrosomia, premature deliveries are higher in GDM pregnancy than normal 
pregnancy (44). In Pakistan, patients with GDM were also found to have a higher 
incidence of preterm labour and caesarean section. In the neonates hypoglycemia and 
hyperbilirubinemia were similarly higher. The fetal abnormality rate was 5.6% and the 
perinatal mortality was 28/1,000 which was higher than the controls (45). In another 
study in Pakistan, pregnancies with a abnormal glucose tolerance showed that 
incidence of pre-eclampsia and caesarian birth were highest in Group with abnormal 
glucose tolerance test. For macrosomia, the incidence increased in those with 
abnormal GCT but normal GTT (46). 
 
Another study in Pakistan was done to look at prevalence and complications in diabetic 
pregnancies in an South Asian community. It found out 3.3%GDM and 0.6% women 
having pre-existing diabetes mellitus. Overall maternal complications were high; pre-
eclampsia (19%), polyhydramnios (4.6%), and threatened abortion (3.4%). Fetal 
complications of macrosomia (13.1%), intrauterine growth retardation (7.1%), and 
intrauterine deaths (5.3%) were noted. Complications were higher in poorly controlled 
groups (47). 
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One study was done in England to look at the fetal and maternal outcomes in Indo-
Asian compared to Caucasian women with diabetes in pregnancy. Pregnancies 
complicated by type 2 diabetes in both groups posed the greatest threat to a successful 
pregnancy outcome. Both maternal and fetal outcome in both these groups were 
similar, but the prevalence of GDM is higher (25% vs 10%) in indo Asian women and 
vaginal delivery had been higher for this population than Caucasian population (40). 
 
Another study in Norway found out that macrosomia, preterm birth, preeclampsia, 
cesarean delivery, APGAR score <7 at 5 min are higher in immigrant women of South 
Asian origin having diabetes during pregnancies (48). 
 
One study was done to look at the nutritional status and birth outcomes diabetic and 
non diabetic pregnancies at BIRDEM hospital in Bangladesh which found out that 
mothers age, anthropometrical measurements like mean height, weight and preterm 
birth have been higher for diabetic mothers from non diabetic mothers (36). The crude 
prevalence of systolic and diastolic hypertension was 6.8 and 5.4%, in a respective 
study conducted in rural community in Bangladesh. The history of abortion, neonatal 
death and stillbirth was found in 19.9, 11.4 and 9.6%, respectively .Higher prevalence 



















1.6 Research questions, hypothesis and objectives of the study 
 




































i). What are the risk factors of GDM in Bangladesh? 
 
ii). Is GDM associated with pregnancy related and neonatal 
complications? 
 
iii). Do pregnancy associated and neonatal complications 
differ according to the time of diagnosis of GDM? 
 
iv). Do pregnancy associated and neonatal complications 
differ according to the type of treatment in GDM? 
i) There exist risk factors of GDM in Bangladesh same as 
those found in other previous and regional studies. For 
instance, Positive family history of diabetes, increased 
maternal age, higher BMI, History of previous GDM. 
 
ii) GDM is associated with pregnancy related and neonatal 
complications. 
 
iii) Pregnancy associated and neonatal complications in 
GDM differ according to the time of diagnosis. 
 
iv) Pregnancy associated and neonatal complications in 
GDM differ according to the type of treatment. 
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3 To identify the risk factors of GDM and to examine the 
relationship of maternal, fetal and neonatal complications with 






























3 To identify the risk factors of GDM in Bangladesh.  
 
3 To examine the relationship between the time of diagnosis of 
GDM and the type of treatment received by them. 
 
3 To measure the association of pregnancy associated 
complications with GDM. 
 
3 To measure the association of fetal and neonatal complications 
with GDM.  
 
 
3 To examine the pregnancy associated, fetal and neonatal 




3 To examine the pregnancy associated, fetal and neonatal 
complication according to the type of treatment received in GDM 
women.  
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• GDM has been seen to be associated with growing pregnancy complication 
by hospital observation in Bangladesh. Urban prevalence of GDM is 
predicted even much more while the rural prevalence was found 6.8% and 
8.2% according to FBG and 2hBG respectively (2).  
 
• According to Millennium development goals complicated pregnancies need 
to be identified beforehand so that pregnant women can make a safer birth 
planning and be attended by skilled health personnel at their delivery. 
 
• Neonatal mortality and morbidity would have also to be reduced in line with 
the targets of MDG. 
 
• Most of the GDM cases progress to diabetes type 2 later in life. In 
Bangladesh diabetes has become highly prevalent and is growing at a faster 
rate. Identification of high risk group like GDM helps to initiate preventive 
measures for them so that the onset of diabetes can be delayed or 






























2. Material and Methods 
 
2.1 Target population 
 
The target population was pregnant women with Gestational diabetes in Bangladesh. 
 
2.2 Study population 
 
The study focused on pregnant women who attended BIRDEM and MCHTI hospitals for 
delivery. 
 
2.3 Study design 
 
A hospital based case control study was designed to collect data for this research 
which was fully quantitative and observational. Two hospitals from the Dhaka city were 
chosen for the collection of data. To collect necessary information a face to face 
interview with the mothers and a retrospective clinical chart review of all the cases 
(GDM) and controls (NonGDM) were done in postnatal phase. 
                    
2.4 Study hospitals  
 
Data for GDM and NonGDM were collected from the women who came to attend 
delivery in BIRDEM and MCHTI hospital in Dhaka City respectively. 
 
2.4.1 BIRDEM hospital 
 
BIRDEM, an autonomous hospital in Dhaka city, belonging to Bangladesh Institute of 
Research on Diabetes, Endocrinology and Metabolic Disorders serves a 
comprehensive health care service for all diabetic patients through out the country at a 
subsidized price. This hospital also provides general treatment to other patients but at 
relatively higher price. As this is the tertiary level hospital and has specialised care 
system for diabetes, quite a significant number of patients with diabetes come to 
BIRDEM hospital from all over the country including Dhaka City. 
 
On an average 3-4 deliveries take place daily at BIRDEM. These are mostly GDM and 
pregestational diabetic deliveries (source: hospital registry). Most of the GDM women 
are referred to BIRDEM from other hospitals or doctors after the diagnosis or suspicion 
of diabetes in them for the better management of diabetes during pregnancy. They are 
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screened off for diabetes by OGTT according to WHO criteria when they are referred 
there. Once their diagnosis is confirmed they are recruited as newly diagnosed GDM 
patient in the hospital. Thereby they can utilize BIRDEM services for both the 
treatments of diabetes and pregnancy care at a subsidized rate. 
 
Cases other than referred ones are usually screened off early in third trimester or in 
second trimester based on the suspicion of the attending doctors in obstetric outpatient 
unit. Thus these women start to receive treatment for diabetes from BIRDEM hospital. 
Their demographic and medical history, clinical and laboratory findings and treatment 
on diabetes are recorded systematically in a book developed by Bangladesh Diabetic 
Association (Appendix-4). At the same time they also go for antenatal checkup in the 
same unit which is recorded in the antenatal card (Appendix-2).  
 
2.4.2 MCHTI hospital 
 
Maternal and Child Health Training Institute (MCHTI) is a tertiary level public hospital in 
Dhaka city. This has been upgraded to a well equipped hospital for obstetric and child 
health care by the assistance of Government of Japan on 2001. This hospital is not a 
specialized hospital for diabetes care or other type of diseases. It mostly renders 
obstetric services to pregnant women at a reasonable price. This hospital has been 
accredited and reputed for holding well-maintained antenatal card (Appendix-3). All of 
the women who deliver here usually have been on their regular antenatal check up. The 
hospital conducts about 10-15 deliveries a day (source: hospital registry).  
 
In MCHTI, the practice of screening for diabetic pregnancies is different. During the first 
or second antenatal check up, it performs a routine test of random blood glucose (RBG) 
irrespective of time of meal to all pregnant women. If that is found equal or more than 7 
mmol/l, they take another RBG test. If that again comes the same as before they are 
asked to take a GCT/ OGTT. If the result of the test confirmed GDM they are referred to 
diabetic hospitals for better and proper management of diabetes. BIRDEM hospital is 
one of those referral hospitals. This is how MCHTI hospital screens out diabetic 
pregnancies and intends to provide routine pregnancy care for the women not detected 







2.5 Research tool/instrument 
 
The following research tool was used in this study for collection of data. 
 
a). Questionnaire (Appendix-1). 
 
Sources for data  
a) Answers from the participants in interview 
b). Antenatal cards (Appendix-2 & Appendix-3). 
c). Diabetic book of the women with GDM (Appendix-4). 
d). Hospital files for delivery and birth records. 
 
 



























a). Women with singleton pregnancy. 
b). Women with any degree of glucose intolerance with 
onset or first recognised during pregnancy. 
c). Women with a diabetic book and antenatal card 
with necessary information for this study. 
      Cases 
 
a). Known history of diabetes before pregnancy. 
b). Women with twin or multiple pregnancies. 
c). Women with a diabetic book and antenatal card 
lacking necessary information for the study. 
Control 
 
a). Women with singleton pregnancy. 
b). Women with an antenatal card with necessary 
information for this study. 











2.8 Sample size 
 
We collected data from 106 cases (GDM) and 196 controls (NonGDM) during the 
period of field work.  
 
In planning phase we estimated a total sample size of 800 with equal number for cases 
and controls. Calculation was performed by a statistician. But in place due to shorter 
period of time and limited logistic support we could not reach up to that many samples. 
 
2.9 Sampling procedure 
 
We underwent continuous sampling for selection of cases and controls for this study. 
 
In BIRDEM hospital 111 women who fulfilled inclusion criteria were asked to take part 
in the study. Among them 5 refused to participate. The rest 106 women with GDM, 
willing to participate, were selected as cases for the study. These women were already 
diagnosed GDM patients by OGTT. They had been on treatment by BIRDEM outpatient 
service for control of their diabetes and pregnancy care.  
 
In MCHTI 266 women who fulfilled inclusion criteria were identified initially. Then they 
were asked for rechecking of random blood glucose level before delivery. Among them 
62 women, declined from giving blood sample to recheck blood glucose level were 
excluded from the study. Blood glucose levels of them were tested from capillary blood 
with a haemocue machine. 8 were found to have blood glucose more than 5.5 mmol/l 
and were also excluded from the study. The rest 196 women had been followed to 
postnatal ward after their delivery.  
 
 
    Control 
 
    a). Women who experienced any degree of glucose 
intolerance before pregnancy.  
    b). Women with twin or multiple pregnancies. 
    c). Women with an antenatal card lacking information 
necessary for the study. 
    d) Women with RBS value equal or more than 5.5 mmol/l. 
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2.10 Pilot study 
 
Prior to the initiation of the main study a small pilot study was performed on 10 subjects 
from each hospital. The intention was to identify the potential problems to collect data 
necessary for the study. Antenatal cards, diabetes record books and delivery cards 
were examined thoroughly to look for the information available and their consistency. 
Due to lack of reliable or sufficient information in the medical records some of the 
variables like microalbuminuria, fasting glycusuria, lipid profile, HbA1C was excluded 
from the study. On the other hand some variables like APGAR at 5, hypoglycaemia in 
babies born to GDM mothers were added. Necessary adjustments were made in the 
questionnaire following the pilot study.  
 
2.11 Data collection procedure 
 
Along with principal investigator two doctors belonged to the respective hospitals took 
part in data collection. They followed the sampling technique to select the sample for 
the study. Assistance of the doctors from respective hospitals was sought because of 
the load of an apparently larger sample size and their easy access to the necessary 
information.  
 
A two days training was provided to the assisting doctors by the principal investigator. 
The training focused on the demonstration of the questionnaire, collection of 
information from the records, operation of the haemocue machine, approach of 
communication and ethical issues. This training was conducted before the pilot phase 
of testing the questionnaire.  
 
Data were collected from July 1 to October 15, 2004 with a structured questionnaire. 
Women selected as cases and controls were interviewed by an investigator in their 
apparently stable situation after the delivery in post natal ward. The purpose of the 
study was clearly explained to them. Those who gave consent to take part, a face to 
face interview was taken and antenatal card and delivery records were reviewed to 
collect the necessary information. Sometimes husband and other family person 
accompanied the woman during the interview and helped her providing information to 
the interviewer. An interview took about 20-30 min. The data were regularly cross 





2.12 Diagnostic criteria used 
 
We depended on the method adopted by respective hospital for screening of GDM. We 
followed the guideline for diagnosis and screening of DM proposed by the clinical 




Fig. 2.1. Screening and diagnosis algorithm for DM based on venous plasma glucose. Red 
arrows explain three different stages of glucose intolerance included in GDM (modified after 
BIRDEM).  
 
In BIRDEM diagnosis of GDM was made by oral glucose tolerance test according to the 
WHO recommended criteria. Thus we included pregnant women detected as cases 
Source: BIRDEM Clinical Research Group, 
GDM 
Screening and diagnosis algorithm based  
on venous plasma glucose 
IFG
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with diabetes or impaired glucose tolerance or impaired fasting hyperglycaemia. Their 
blood glucose value represented the venous plasma glucose value undertaken in 
oxidase method. The values of diagnostic criteria are described in the following table 
(Table 3). For controls random blood glucose which represented the venous plasma 
glucose value below 5.5 mmol was considered in the way mentioned earlier. 
 
Table 3: Values for diagnosis of diabetes mellitus and other categories of  
hyperglycemia by the OGTT. Glucose concentration mmol/l (mg/dl) 
 










Impaired Glucose Tolerance 
(IGT) 
Fasting (if measured) 









≥ 7.8(≥140) and 
<11.1(<200) 
Impaired Fasting  glucose 
Fasting 
 










              

















In this study GDM is the only dependent variable. All others are independent variables 
 













2.13.2 Time of diagnosis of GDM 
              
Gestational week at which GDM was diagnosed     
 
2.13.3 Type of treatment in GDM 
            
Diet control or insulin whichever was received by the women  
with GDM for longer duration. 
 














i) Socio demographic risk factors: Maternal age, First recorded 
maternal weight in this pregnancy, Height, BMI, Level of 
education of the women, monthly expenditure of the family and 
occupational status of the women. 
ii) Familial risk factor: Family history of diabetes and first and 
second degree relatives. 
iii) Obstetric risk factors: Gravidity, previous adverse obstetric 
history and previous history of GDM. 
       
       i). Pregnancy complications: Hypertension in pregnancy,   anaemia 
       ii). Delivery outcome: Gestational age at delivery, Mode of delivery. 
iii). Fetal and neonatal Outcome: Birth weight of the newborn, Normal 
live or abnormal birth of foetus or babies, APGAR score at 5 min. 
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Maternal Age: Age of mother at the current pregnancy. 
 
Pregnancy weight: First recorded weight in the antenatal card during this 
pregnancy. 
 
Maternal Height: Height recorded in the antenatal cards. 
 
Pregnancy BMI: Body mass index was calculated by pregnancy weight (in kg) 
divided by height (in meter) squared. 
 
Years of education: Numbers of years until which our study population have 
received institutional education. Years of education are further subdivided into 
primary, secondary, higher secondary and higher level of education. 
 
Occupational status: We have looked into whether the woman is housewife or 
not as the number of women working outside home or directly involved in 
income generation is very limited. Women who are not directly involved in 
income generation activity we referred them as housewife in our study. 
Mentionable housewives, who were student, were not put into house wife 
category. 
Monthly expenditure: The monthly expenditure of the family in taka (local 
currency). This includes expenditure irrespective of structure of the family 
whether small or large. 
 
Intra-uterine death: A fetal death occurred inside the mother’s womb after 24 
weeks of pregnancy. Women usually felt no fetal movement before the onset 
of labour. 
 
Gravida: Number of conception by our study population including the current 
pregnancy. It includes miscarriage, abortion, still birth and events of menstrual 
regulation. 
 
Miscarriage: A fetal death in early pregnancy. It refers to death of fetus early in 
pregnancy or more precisely before 24 week of gestation. 
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Still Birth: It means the birth of a dead fetus late in pregnancy which happened during 
the process of delivery. 
 
Hypertension recorded in pregnancy: Presence of high diastolic blood pressure in two 
or more antenatal check-up that is recorded in antenatal card or women taking 
antihypertensive drugs. Two records of diastolic blood pressure ≥ 90 mm Hg in 
antenatal card has been taken as hypertension in pregnancy for this study. 
 
Anaemia: Hemoglobin level <11mg/dl in pregnant women. 
 
Gestation at delivery: Gestational week of pregnancy at which delivery takes place. In 
this study it was calculated from menstrual history. 
 
Mode of Delivery: Mode of delivery was categorized into normal delivery and caesarean 
section. 
 
Pre-term birth: Less than 37 completed weeks (less than 259 days) of gestation.  
 
Live Birth: Live birth was taken as when the newborn breathed or showed any sign of 
life .These were presence of heart beat, pulsation in the umbilical cord or movements of 
voluntary muscle. 
 
Birth weight: The first weight of the newborn obtained after birth. In both the hospital 
they recorded babies’ weight by digital baby weighing machine. 
 
Apgar score: Evaluation of a newborn’s physical status by assigning numeric values (0 
to 2) to each of the 5 criteria: 1) heart rate, 2) respiratory effort, 3) muscle tone, 4) 
response to stimulation and 5) skin color. In this study the recorded score at 5 min of 
birth has been included. 
Low birth weight (LBW): Birth weight less than 2500 gm (up to and including  
2499 gm). 
Macrosomia: Birth weight more than 4000 gm. 
 
Hypoglycemia of infants: Blood glucose level of infants recorded below 2.5 
         mmol/L. 
 
2.15 Data handling and analysis 
 
Individual case was given a case number to avoid mixing up of data. In the field data 
were entered into Microsoft Access 98 according to pre-coded categories. Later this 
data were converted into the software package SPSS 12.0.1 (Statistical Package for 
Social Sciences) for windows operating platform. The data were checked by going 
through each and every questionnaire.  
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SPSS 12.0.1 was used to examine the frequency distributions of maternal socio- 
demographic characteristics, family and obstetric histories, pregnancy and neonatal 
outcomes according to case and control status. For a general description of the study 
population group differences were recorded in x2 test, while individual t-test was 
employed to identify differences for some of the continuous variables. Initial univariate 
analyses were carried out to determine crude odds ratios (ORs) and 95% confidence 
interval (CI). Effect modification was evaluated in multivariate logistic regression 
models. If there appeared to be no effect modification, logistic regression procedures 
were used to simultaneously control for confounding variables while estimating ORs 
and 95% CIs. Final logistic regression models included confounders as well as those 
covariates of a priori interest. Statistical significance was set at <0.05. 
 
2.16 Ethical issues 
 
Approval to carry out the study was sought from the Ethical Review Committee in 
Norway and from the Bangladesh Medical Research Council before the 
commencement of the study. It was approved by the countries. The purpose, objectives 
of the study and possible benefits of the study were explained to the relevant authorities 
at BIRDEM and MCHTI. 
 
Prior to interview, the purpose and objectives of the study was explained to the 
prospective participants. Decision to join in the study was made on the basis of 
informed consent. Verbal consent to take part in this study was sought prior to their 
inclusion to this study in presence of a witness (Appendix-5). Participation in this study 
had been voluntary and participants had the right to withdraw at any period of the 
investigation. No penalty was attached to such decisions. The findings were treated 
with highest possible degree of confidentiality. Each participant was given a separate 
identity number. 
 
In cases of adverse pregnancy outcome like complicated delivery, mother’s and baby’s 
illness or in any emergency situation psychological effects of the participants had been 
taken care of while asking question or collecting information. Researchers were 



































The findings in this study will impart on the data collected from two hospitals in Dhaka 
city from July 1st to 15th of October 2004. A total of 106 women from BIRDEM and 196 
women from MCHTI were interviewed during this period. The data were based on the 
answers came from interviews and medical records registered in the antenatal cards, 
diabetic booklet and delivery notes in hospital files. Medical records were reviewed 
retrospectively for information on medical history, physical findings, course of the 
disease, treatments, complications, and outcomes in accordance with the objective of 
the study. It is noteworthy that all the women in this study dwelt in either urban or semi 
urban areas. 
 
In this chapter results will be divided into three parts. First, descriptive analysis of the 
risk factor variables will be presented followed by multivariate analysis. Secondly, the 
association of the time of diagnosis of GDM with the type of treatment received by the 
women will be described. Finally, we will compare pregnancy outcomes of GDM by 
univariate and multivariate analysis between cases and controls. We will also compare 
pregnancy outcomes in GDM according to the type of treatment received by the women 
and time of diagnosis of GDM made in this pregnancy. 
 
3.1 Risk Factors for GDM 
 
Maternal age, pregnancy weight, height, level of education and occupational status of 
the women, monthly expenditure of the family, and family history of diabetes, gravidity 
and previous obstetric history were examined to identify risk factors of GDM. 
 
3.1.1 Demographic factors 
 
3.1.1.1 Maternal Age  
 
Women with GDM have been seen to have an increase of prevalence with increasing 
age of pregnancy. The mean age of GDM and NonGDM group was 29.6 ± 4.1 and 
24.3± 5.2 respectively. About 86.8% of women in GDM group were over 25 years. No 
woman under the age of 20 was found in the cases. On the contrary we observed 
17.3% women in control group below 20 years. But the lowest recorded age in GDM 
group was 21 years. The prevalence proportion of GDM increased with age from 13.2 














     
 
Fig. 3.1 Prevalence percentage in different age group in GDM and Control group. 
 
Larger difference of prevalence was also marked between GDM and the control group 
(14.2% vs. 4.1%) in the women over 35 years. The distribution of age in control group 
was noticed to have a predominance of younger age pregnancy than GDM group. In 
bivariate analysis we have seen that risk for GDM was higher in the women from 25 
years and above. We observed a significant difference (p value <0.001) in the 
distribution of age between GDM and control group (Table 4). 
 
3.1.1.2 Anthropometric findings 
 
Anthropometrical measurements in this study were derived from medical records 
provided in the antenatal cards. We found a preponderance of heavier women in GDM 
group in comparison to the control group as there was a marked difference on the mean 
weight of both the groups (61.7± 9.1 vs. 56.4 ± 8.7). Individual t-test had shown 
significant difference in distribution of weight in between the groups (p value <0.001). In 
this study the mean height of women in GDM and control group was 153.4 ± 5.3 and 
153.7 ± 5.1 cm respectively. In individual t-test the distribution of height didn’t reveal 
any difference (p value <0.61) in between these two groups. The measurement of 
obesity depends on the proportion of both the height and weight of an individual. 
< 20 20-24 25-29 30-34 ≥ 3  
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Therefore we focused on the BMI of the women in order to examine the relationship of 
obesity with GDM. Based on the recorded weight and height, we calculated BMI of 
each participant.  
 
 
Table 4:  Demographic factors and their association with GDM in the study population 
 
 
Distribution Risk estimation for GDM 
Category GDM Non GDM 
Count           % Count           % 
Crude Odds ratio (95% Cl) 




                      3.5(1.8-7.0) 
11.02(4.7-26.1) 
  
14               13.2 
  0                 0.0 
47               44.3 
30               28.3 
15               14.2 
 
  72           36.7 
  34           17.3 
  68           34.7 
  14             7.1 







Body mass index ÂÂÂ  
≤20 
                            
                          1.00   22            11.4 
109            56.4 
  3                 2.9 
40               39.2 
47               46.1 





2.6(0.7-9.3)   54            28.0 
    8              4.1 11.0(2.4-49.4) 
ÂÂÂp value<0.001 
 
In this study women with GDM were found obese in relation to the control group (Table 
4). The mean BMI of women with GDM was 26.2±3.6 and the control group 23.8±3.6. 
Seventy five percent of the women in GDM group had BMI over 24 while seventy five 
percent of women in the control group had below 26 (Fig. 3.2). In descriptive analysis 
chi square test revealed significant difference of obesity in between these two groups. 
Risk of GDM was about 11 times [OR 11.0; 95% CI (2.4-49.4)] more in the women with 































Fig. 3.2 Means, fractile and distribution of BMI in GDM and control group. 
 
3.1.2 Socio- economic factors 
 
3.1.2.1 Level of education 
 
It has been seen that women with higher level of education had GDM more than those 
with less institutional education (Fig. 3.3). Meanwhile, highest level of education 
attained by the women of this study was classified in different level ranging from 
primary to higher education. The difference was highest in the women with higher 
education (29% vs. 12%). The proportion of prevalence was also higher (37.7%) in 11 
to 14 years group. But the difference turns into the opposite direction (26.4% vs. 51%) 












   














Fig. 3.3 Prevalence percentage of women with GDM and the control group according to their 
level of education. 
    
 
However, women having primary level of education had almost the same percentage in 
these two groups (Table 5). The mean years of education were 12±3 for women with 
GDM and 10 ±3 for women in the control group. Risk of GDM appears to be more in the 
women with education more than 14 years [OR 2.3; 95% CI (0.8-6.9)] than those with 5 
years of education. Chi square test displayed that level of education in between the 



















 Table 5:  Socio- economic factors and their association  
with GDM in the study population 
 
 
Risk estimation for GDM Distribution 
in Bivariate analysis 
GDM 
Count           % 
Non GDM 
Count           % 
Category Odds ratio (95% Cl) 
Years of education ÂÂÂ                                   
 
0-5 
 6-10  
      11-14 
        >14  
  
  7                6.6 
28              26.4 
40              37.7 
31              29.2 
 
 12               6.2 
 99             51.0 
 60             30.9 






Occupation  ∆                                                
Others 
House wife 
20               18.9 
86               81.1 
 28             14.4 
 167           85.6 
1.00 
0.72(0.4-1.3) 





1.00  61             13.0 12             (11.7) 
2.3(1.1-4.7)  99             53.8 45             (43.7) 
 24             13.1 46             (44.7) 
∆ not significant 
ÂÂÂ p value <0.001 
 
3.1.2.2 Occupational status of mothers 
 
All the women in this study were married and most of them were housewives (Table 5). 
About 81 % in GDM and 86% in the control group were found as being solely 
housewives. According to the answers provided by them these women were involved 
only in household activities and didn’t have any other working status. Types of 
occupation seen to be hold by the women in this study were clerical and officer post in 
the government service, bank, hospitals and NGOs. These women were described 
under ‘others’ category. The operational definition of house wife was described in 
methodology chapter. Chi square test revealed no difference of occupational status in 











3.1.2.3 Monthly expenditure of the family 
 
Women having better economic status were more likely to have GDM than those 
having low economic status in these study population (Table 5). Only 12 % of women 
with monthly expenditure less than 5000 taka ($87) were found to have GDM. It has 
been noticed that GDM increased with increasing monthly expenditure of the family 
(Fig. 3.4). The difference was highest in those with monthly expenditure more than 
10000 taka ($154) (44.7% vs. 13.1%). In univariate analysis significant difference was 
observed (p value <0.001) in between these two groups. 
 
Those who had monthly expenditure more than 10000 taka (≥$154) had about 9.7 
times more risk of GDM [OR 9.7; 95% CI (4.4-21.5)] than those had less than 5000 taka 
(Table 5). 
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 3.1.3 Family history of diabetes 
 
Family History of diabetes was found as a strong risk factor for GDM and significantly 
associated with GDM in this study (p value <0.001) (Table 6). About seventy four 
percent women  with  GDM  answered ‘yes’ when they are asked whether any in their 
immediate relation like parents, siblings, children, uncles and aunts, grant parents have  
known history of diabetes. On the contrary about 26% responded as ‘yes’ to this 
question in the control group. We noted that the risk of GDM in the women with a 
known positive family history is 8.7 times more than [OR 8.7; 95% CI (4.6-16.4)] those 
who didn’t have 
( Table 6). Quite a large number of women replied that they did not know whether any 
in their family had diabetes in both the groups. Meanwhile, most of them belonged to 














Fig. 3.5 Distribution of the participants on family history of diabetes. 
 





Odds ratio for GDM 
In bivariate analysis 
(95% confidence interval) 
Known family history of diabetesÂÂÂ                            
1.00 84 (46) 17 (16) No 
8.7 ( 4.6-16.4) 
0.6 (0.2-1.6) 
47 (26) 83 (78.3) Yes 
50 (27.6) 6 (5.7) Unknown 








3.1.4 Obstetric factors of the mothers 
 
3.1.4.1 Previous history of GDM 
 
In our study all the women who had GDM in their previous pregnancy (26%) developed 
GDM in the current pregnancy while no one in the control group had GDM in their 
previous pregnancy (Fig. 3.6). Women who were primi gravida or had prior history of 
menstrual regulation or miscarriage were excluded in the previous obstetric history 
analysis. Previous history of GDM was found to have a significant association with 
GDM. A positive history of GDM in the previous pregnancy predicts high risk for GDM in 
the following pregnancies [OR 2.1; 95% CI (1.7-2.6)] (Table 7). 
 





Yes No Unknown Not Applicable
 





Yes No Unknown Not Applicable
 
Fig. 3.6 Prevalence percentage of Previous history of GDM in current GDM and the control 
group. 
 
Table 7. Characteristics of obstetric factors and its association  






Variables Odds ratio for GDM 
(confidence interval) 











2.3 (1.2-4.4) 66 (33.7) 




1.00 0 (0) 27 (26) 
2.1 (1,7-2.6) 48 (29.1) 44 (42.3) 
0.3 (0.2-0.7) 47 (28.5) 15 (14.4) 
Previous adverse obstetric history   p<0.01  
Yes 37 (34.9) 35 (17.9) 1.00 




3.1.4.2 Previous adverse obstetric history 
 
We looked for history of miscarriage, still birth including intrauterine death (IUD), live 
birth with congenital anomalies and preterm birth in the previous pregnancies of our 
participants. We found higher incidence of miscarriage and still birth and IUD in GDM 
compared to the control group (Fig. 3.7). In contrast only one in GDM group had 
preterm birth in their previous pregnancy while no one had a history of live birth with 
congenital anomalies in either of these groups. Due to lower occurrence rate of these 
events in their past pregnancies we put all them under ‘previous adverse obstetric 
outcome’ during analysis instead of taking them separately. In univariate analysis an 
adverse obstetric history in the previous pregnancy displayed significant difference in 
between the groups and found it as a risk factor for GDM in the following pregnancy 
(Table 7).  
                      




















Most of the women in GDM group were multi gravida (83%). It has been seen that the 
prevalence percentage of GDM increased with gravidity while it remained almost static 
in control group (Fig. 3.8). In chi square test gravidity appeared to be significantly 
associated with the incidence of GDM. The risk of GDM in multi gravida (two or more 
gravida) was seen about two and half times more than that was in the primi (Table 7). 
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3.1. 5 Risk factors for GDM in multivariate analysis 
 
When all the associated risk factors (p<0.05) with  GDM  were put in a logistic 
regression model positive family history of GDM, maternal age more than 25 years and 
BMI in pregnancy <23 was explored as independent predictors for GDM (Table 8). 
Other factors those which displayed association with GDM in descriptive analysis might 
have influenced by confounding factors. Hence level of education, monthly expenditure, 
gravidity, and previous bad obstetric history was not appeared as independent risk 
factor for GDM in multivariate analysis. It is worth to note that we dichotomized all these 
variables to analyze them by multivariate model. For example, level of education was 
dichotomized to, equal and less than 10 years and more than 10 years and monthly 












Table 8: Independent predictors for GDM in multivariate analysis 
 
OR (CI) P value  
Positive family history of diabetes 7.9(1.9-32.8) 0.023 
Maternal age   > 25years 5.0(1.2-21.6) 0.027 
Pregnancy BMI   > 23 5.9(1.3-27.4) 0.004 
 
After adjusting for Maternal age, BMI, family history of diabetes, previous history of GDM, level of education, monthly 
expenditure, gravidity, previous bad obstetric history altogether in logistic regression model. 
 
Based on the findings of multivariate analysis we looked into proportion of risk factors in  
our study population .About 56% on average of our study population had one risk factor 
while about 43%  had two risk factors. Individual percentages were presented in Table 
9. 
 
Table 9. Prevalence proportion of women with one or  
more than one independent risk factor 
 
Risk factor GDM (% within GDM) Control (% within control)
Age >25 84.0 34.7 
Positive Family history 85.2 48.6 
BMI >23 83.0 35.9 
Age>25+ Positive family history 70.0 16.0 
Age >25+BMI>23 70.5 22.3 






3.2 Time of diagnosis of GDM and its relationship  
with type of treatment received 
 
In this study we noted down the gestational week of diagnosis of GDM and the main 
treatment received throughout the pregnancy for GDM mothers.  The mean gestational 
week for diagnosis of GDM was 23±8 (median is 25 week) .About 43 % were 
diagnosed before 20 week of gestation. The earliest diagnosis was made at 7 weeks 
and the latest was at 38 weeks. We categorized the time of diagnosis in two groups. If 
the diagnosis was made  before 20 weeks of gestation that is put in ‘early diagnosis’ ,on 
the other hand If  the diagnosis was made at 20  weeks or  after that then that is put 
under ‘late diagnosis’ .Out of 106 GDM patient 45 were diagnosed in early and 61 in 
late pregnancy in the study( Fig.3.9). 
 
In our study 41 women were treated with diet and 64 with insulin. We came across one 
woman who didn’t receive any treatment as was not diagnosed until onset of labour. 
This woman was excluded in the analysis.  
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In our study we noticed that women who were diagnosed in early phase were more 
likely to be treated with insulin than those who were diagnosed late (Figure 3.9).  Chi 
square test showed that type of treatment received by the women was significantly 
associated with the time of diagnosis of GDM. Univariate analysis revealed that risk of 
being treated with insulin was 3.7 times higher in the women diagnosed early than 
those diagnosed late (Table 10). 
 
 
              
Time of diagnosis
















Fig. 3.9 Prevalence percentage of treatment with diet and insulin in women with GDM 
according to phase of diagnosis. 
 
 
Table 10: Association of  the main treatment received during pregnancy with  




Insulin Odds ratio (CI) for Insulin   
(64) 
Time of diagnosisÂ 
Late      (60) 31 (75.6) 29 (45.3) 
 
ÂP value< 0.05 
 





3.3 Pregnancy outcomes 
Pregnancy outcomes were presented as pregnancy complications i.e. anemia, 
hypertension in pregnancy, delivery outcome i.e. gestation at delivery, mode of 
delivery, fetal outcome i.e. live or abnormal birth, neonatal outcomes i.e. birth weight 
and Apgar at 5 min.We compared the pregnancy outcomes between cases and 
controls and also in between GDM mothers grouped by time of diagnosis of GDM and 
type of treatment they received parts. 
3.3.1 Comparison of pregnancy outcomes between GDM and NonGDM  
 




About 18 % of women in GDM were found to have anemia when the cut off value for 
Hb% was set off at 11 mg. The percentage was about 4 times high in the control group 
in contrast to GDM group (Table 11). The mean hemoglobin level in GDM group was 
11.8±0.9 whereas in control group that was 10.8±1.2. Only 2 in the control and none in 
GDM group was found to have Hb <8mg/dl. P value shows there is a significant 
differences in between the groups on being anemic in this study .In this  study we  
found that control group was more likely to  have moderate anemia in pregnancy than 
the GDM group . 
 







Odds ratio for GDM 
(95% CI) 
Anaemia   p<0.001  
Anaemic 16 (18.4) 114 (60.3) 1.00 
Non-anaemic 71 (81.6)   75 (39.7) 0.15 (0.1-0.3) 
Hypertension in Pregnancy  p<0.05 
No 93 (87.7) 188 (95.9) 1.00 
Yes 13 (12.3)   8 (4.1) 
 
3.3.1.2 Hypertension in Pregnancy 
 
Those who were found to have high blood pressure recorded twice or more in 
pregnancy during the antenatal checkup were taken as having hypertension in 
pregnancy. The occurrence of hypertension was high in GDM group in contrast to the 
3.3 (1.3-8.2) 
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NonGDM group (Table11). Hypertension in pregnancy differs significantly between 
these two groups (p value<0.05). In bivariate analysis the risk of GDM was found 3 
times more in the women with GDM than those without GDM. 
b). Complications in delivery  
3.3.1.3 Gestation at delivery 
Preterm birth (<37 completed weeks) was found to be more prevalent in the GDM 
pregnancies than the normal pregnancies. Prevalence proportion varied markedly in 
between 32-36 weeks of delivery in these groups (Figure 3.10). But before 32 weeks 
the percentage of preterm birth in both the groups was almost same (Figure 3.10a and 
b). Very small number of cases (8) in GDM group continued until full term. But in 
NonGDM most of the pregnancies ended at term. A significant difference was noticed in 
the gestation at delivery in between these two groups in univariate analysis. The data 
showed women with GDM have more than three times risk of preterm delivery [OR 3. 6; 
95% CI (1.9-6.8)] than that of women with NonGDM (Table 12).    
Distribution of gestation at delivery 






































Odds ratio for GDM 
(95% CI) 
 Gestation at  delivery  ÂÂÂ                       
1.00 178 (90.8) term 69 (65.1) 






Normal 153 (79.1) 1.00 23 (21.7)           
83 (78.3) caesarean 41 (20.1) 
   




3.3.1.4 Mode of delivery 
  
Our data revealed that only 21% normal delivery happened in GDM pregnancy. 
Occurrences of caesarean delivery in GDM were much higher (78.3% vs 20.1%) in 
relation to normal delivery. It is worth to note that we didn’t investigate the indication of 
caesarean section in our study. In descriptive analysis significant difference was 
observed in between these two groups (p value <0.001) (Table 12). 
 
c). Fetal and Neonatal complications 
 
3.3.1.5 Outcome of fetus 
 
About 4.7% of intrauterine death was noticed in GDM pregnancy. The number was 
relatively low in NonGDM group (1.5%). Two live born babies with congenital anomaly 
were found in GDM group. No still born birth was not taken place in this study in GDM 
group where as 4 cases of still born birth happened in the control group. It can be noted 
that one of those was minor (cleft palate) and the other one is major (single ventricle) 
type of birth defect. In this study no congenital anomaly were found in NonGDM group. 
We assembled the number of IUD, still born birth, birth with injury, and birth defects 
under the group of abnormal birth to calculate the odds ratio in relation to normal live 
birth. Univariate analysis revealed that risk of abnormal birth in GDM pregnancy was 
about two times [OR 1.9; 95% CI (0.6-5.8)] more than that of normal pregnancy .But chi 
square test in descriptive analysis didn’t find any significant difference on the 





3.3.1.6 Birth weight 
 
About 19% of the birth in GDM group had birth weight more than 3.5 kilogram. But only 
one was found to be born with macrosomia (birth wt. > 4 kg) in this study in GDM group. 
The mean birth weight in GDM and the control group had been 3.04±0.46 and 
2.77±0.41 respectively. Percentage of low birth weight was 5.7% in GDM and 18.1 % in 
Non GDM group if we consider cut off value 2.5 kg. Only 2 in GDM and but 11 in Non 
GDM had birth weight less than 2 kilogram. Cumulative proportion of birth weight of 
newborn born to GDM mothers in this study runs above that of control group above 3 
kilogram but before that it had been lower than the control group (Fig 3.11).This means 
the number of heavier baby were more in GDM group above three kg.We have seen 
that prevalence proportion of birth weight above three kilogram is more (60%) in GDM. 
P value revealed significant difference in distribution of birth weight in between these 
two groups. Risk for having a baby over 3.5 kilogram in GDM was found  to be about 




































<2 2-2.4 2.5-2.9 3.0-3.4 >3.5
















ÂÂÂ p value < 0.001,  ÂÂ p value <0.01 ,∆  not significant 
 
3.3.1.7 Apgar at 5 minutes 
 
Among the newborn babies 4.5 % in GDM and 2.7% in the control group had Apgar 
score below 7 at their 5 min of age. However this difference was not statistically 
significant (p value > 0.05).Univariate analysis revealed that risk apgar less than 7 at 5 
min in GDM pregnancy was about twice of who don’t have diabetes (Table13). 
 
 
3.3.1.8 Pregnancy outcomes in multivariate analysis 
 
When all the associated pregnancy outcomes  (p<0.05) with GDM were computed in a 
logistic regression model birth weight > 3.5 kg, incidences of caesarean section, 
Variables GDM Non GDM 
Count (%) 
Odds ratio for GDM 
(95% CI) Count (%) 














































20(18.9) 12 (6.2) 1.00 
183(93.8) 3.5(1.6-7.5) 86(81.1) 
 
Birth weight <2.5 kgÂÂ 
>2.5 6( 5.7) 35(18) 1.00 
0.3(0.1-0.7) <2.5 100(94.3) 159(82) 














preterm delivery , hypertension in pregnancy and hemoglobin level were found to have 
independent association with GDM pregnancy .Thus GDM predicted for a birth weight 
more than three kilogram, caesarean section, preterm delivery (before 37 completed 
weeks) and hypertension in pregnancy  and  not likely to have  anemia during 
pregnancy (Table 14). 
 
Table 14: Pregnancy outcomes from GDM pregnancy in multivariate analysis 
 
ÂAdjusted OR (95% CI) P value  
Birth weight > 3.5 kg 1.8(1-2.9) 0.03 
Caesarean section 11.7(5.6-24.3) 0.000 
Preterm delivery 7.2(2.3-22.8) 0.001 
Hypertension in pregnancy 3.8(1.0-13.3) 0.044 
Hb% 0.2(0.1-0.3) 0.000 
 
Â when adjusted for birth weight > 3.5 kg, Birth weight <2.5 kg,caeserean section, preterm delivery , 
hypertension in pregnancy and hemoglobin level in logistic regression model. 
 
3.3.2 Pregnancy outcome according to period of GDM diagnosis 
 
Comparison between early and late diagnosis group in GDM 
 
We compared the outcome of women who were diagnosed early with those who were 
late according to the aim of the study. Again we also compared them separately with 
the outcome of control population. 
 
No significant difference was observed between the groups with early diagnosis and 
late diagnosis except the events of hypoglycaemia. Hypoglycaemic episodes were 
about three times more likely to occur in the early diagnosed group than that in the late 
















Table 15: Characteristics of pregnancy outcome according to time of diagnosis of GDM 







Count          % 
Late 
 





Hypertension in Pregnancy  
Yes 
no 
  8 17.8 8.2  5 2.3(0.7-7.7) 
37 81.2 56 91.8 1.00 
ns 
 






*-p value < 0.05, ns – not significant,  
Reference value (1.00) is shown in the lower row. 
¤Stillbirth,IUD,Birth injury and Congenital anomaly 
 
Hypertension in pregnancy was seen to be significantly associated with the group who 
were diagnosed as GDM in early pregnancy when we compared both these two groups 
with the control or background population. We also found preterm delivery and birth 
weight > 3.5 kg is more significantly associated with the women with GDM who were 
diagnosed late in pregnancy (Table 16). 
Yes 
no 












24.4 27.917 0.8(0.3-2.0) 
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     80.0 7747 1.2(0.5-3) 
no      20.0 14 23 1.00  
Outcome of fetus 
¤Abnormal 
 
ns 8.9 4.9 4 
41 
  3 1.9(0.4-8.9) 
 normal  91.1 58 95.1 1.00 





10 22.2 16.410 
35 83.6
1.4(0.5-3.8) 
77.8 51 1.00 
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2 < 2.5kg 4.4 6.6  4 
≥2.5kg 43 93.4
0.7 (0.1-3.7) 













Apgar  score at 5 min 
<7 
≥7 
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Table 16: Comparison of pregnancy outcomes in early and lately diagnosed  






Early diagnosed GDM vs 
control group (46 vs 196) 
Late  diagnosed GDM vs 
control group (60 vs 196) Variables 
OR(95% CI) p value OR(95% CI) p value 




 *** *** 0.2(0.1-0.4) 0.1(0.06-0.31) Anemia 0.000 0.000 
** *** 4.2(2.0-8.8) Preterm delivery 3.1(1.4-7.3) 
0.009 0.000 




¤ Abnormal outcome of fetus 2.5(.7-8.8) 1.3(0.3-5.4) ns 
0.468 




0.2(0.1-1.0) * 0.3(0.1-0.9) * Birth weight<2.5 
0.014 0.019 
Apgar  at 5 min < 7 
*p value <0.05,  **p value <0.01,  ***p value <0.001 
¤ Stillbirth, IUD, Birth injury and Congenital anomaly 
 
 
3.3.3 Pregnancy outcome according to type of treatment 
 
Pregnancy outcome in GDM didn’t differ according to the type of treatment the women 
with GDM received when compared between them. But like time of diagnosis GDM 
occurrence of hypoglycemia appeared to be significantly associated with type of 
treatment. Risk of hypoglycemia was about 5.6 times more in the group treated with 



















Table 17: Characteristics and relationship of pregnancy outcome  
according to type of treatment received in GDM 
 
Insulin over diet  
 
 
** p value < 0.001, ns – not significant 
Reference value (1.00) is shown in the lower row. 
¤ Stillbirth, IUD, Birth injury and Congenital anomaly 
 
 
When diet and insulin treated group compared with control group separately 
hypertension in pregnancy was found only to be associated with the women treated 
with diet. We also found that preterm delivery was more significantly associated with 
the women treated with insulin. Our study revealed that risk of having birth weight more 
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4 2.8(0.8-9.2) 23.4 9.8 




































































Table 18: Relationship of pregnancy outcome in women treated with diet and exercise  
and insulin in comparison to control (Non GDM) population 
 
Diet group GDM vs control Insulin group GDM vs  control  
(41 vs 196) (64 vs 196) 
 
p OR(95% CI) OR(95% CI) p value  
value  
 
*p value <0.05,  **p value <0.01,  ***p value <0.001 














Hypertension in Pregnancy 5.5(1.9-15.6) * 1.9(0.6-6.1) ns 
Anemia 
 
0.1(0.04-0.3) ** 0.2(0.1-0.4) ** 
Preterm delivery 3.5(2.1-8.6) * 3.7(1.8-7.8) ** 
Caesarean section 10.6(5.0-23.5) ** 15.4(7.6-31.0) ** 
¤ Abnormal outcome of fetus 1.3(0.3-6.7) ns 1.8(0.5-6.2) ns 
Birth weight  ≥3.5kg 1.6(0.5-5.4) ns 4.6(2.0-10.6) *** 
Birth weight  <2.5kg 0.2(0.1-1.0) * 0.3(0.1-0.9) * 





























The objective of the study was to examine the risk factors and pregnancy outcome of 
gestational diabetes in Bangladesh. This was set to serve the purpose of getting an 
overview of risk and effects of gestational diabetes in Bangladeshi population.  
4.1 Methodological consideration 
4.1.1 Study design 
A hospital based case control study was chosen in order to get a preliminary overview 
of the risks as well as effects of GDM in Bangladesh. We acknowledge some caveats in 
our study as 29% women come to the hospital for pregnancy care and delivery in 
Bangladesh (50). Despite of this fact a hospital based study is the most convenient way 
to select a group of pregnant women and a low cost method to obtain a health service 
data because of lack of infrastructure. We agree that a prospective study in hospital 
settings would have been more appropriate to establish epidemiological causation of 
risk factors and effects of GDM. But such type of study is very time and resource 
intensive. So in order to meet the objectives in shorter time and in limitation of logistics 
and resources we chose a case control design instead. We sought to collect data 
retrospectively from the pregnant women after the delivery in order to obtain necessary 
information on both the pregnancy events and risk factors. We selected the control 
group to get the reflection of distribution of study factors similar to cases. Thus a case 
control study enabled us to compare strength of association of risk factors and 
pregnancy effects in between GDM and Non GDM population (51). 
 4.1.2 Selection of hospitals 
In the beginning we intended to collect both the cases and controls from BIRDEM. As 
we mentioned previously that diabetic hospital (BIRDEM) delivers the cheapest and 
standard diabetic care to all groups of diabetic patients but general health service are 
provided at a standard cost. Therefore cases and controls would have varied by 
socioeconomic factors. So, we went back to another hospital (MCHTI) which would 
have a representation of general population in order to recruit control group. 
In selection of hospitals we also prioritized the availability of systematized medical 
record of pregnancy. Hence, after a small survey in some public hospitals in Dhaka city 
we chose MCHTI hospital. MCHTI has been accredited for systematized obstetric 
health service to general people in Bangladesh.  
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4.1.3 Diagnostic criteria of GDM in cases and controls 
We were unable to screen off GDM by a same diagnostic test to differentiate cases and 
controls for our study. One of the reasons behind this was any uniform or standard 
protocol for screening of GDM has yet not been practiced in public hospitals of 
Bangladesh. The other one was we aimed to collect data from the women after 
delivery. Therefore it was not possible for us to carry out a screening beforehand for a 
required number of samples within shorter period of study. However, both the hospitals 
have their own protocol to screen GDM and we had to carry out our study based on 
that. BIRDEM followed WHO criteria (46) so that the cases of GDM we selected for this 
study were true GDM cases.  
On the other hand MCHTI assesses random blood sugar and screens out women as 
nondiabetic if the result comes below 7mmol/l.By taking 5.5 mmol as cut off value we 
included  women unlikely to have any diabetes (49). This cut off value was 
recommended in standard guideline of diagnosis and management of diabetes 
proposed by Clinical Research group BIRDEM (52). 
4.1.4 Sampling technique and sample size 
We conducted continuous sampling to reach the required number of sample size. But 
as mentioned earlier due to lack of resources and time we could not collect according to 
our estimates. However the study was able to include a good number of cases than 
many other previous studies done on it.  Thus the sample size enabled us to analysis 
and interprets the result in most of the occasion. 
4.1.6 Response of the participants and data collection 
We depended on the information provided to us by the participants. As in our setting 
the availability of birth registration, previous medical records, data on socioeconomic 
condition etc are rare we don’t have any existing system of verification of the answer 
made by them. We were able to recheck those from antenatal and delivery records in 
case of recall problem and misleading information. The information available in the 
patient journal or hospital registry is often insufficient and incomplete. Hence we chose 
to interview the women after delivery and check the medical records of the pregnancy 




4.2 Methodological discussion 
Even though this methodology was examined to focus on objectives, some questions 
on its strength and limitation can be raised. 
4.2.1 Strength of the study 
4.2.1.1 Pretest 
A pretest was undertaken in 10 of cases and 10 of controls from respective hospital to 
examine the data collection tools and sampling procedure and to assess the reaction of 
the respondents to our research procedure. This enabled us to obtain a range of 
possible answers for our questions.We had to take away history of large baby when we 
saw most of our patients could not provide any medical documentation or recall 
correctly how large their baby was at birth. This is how we also integrated Apgar at 5 
min and Hemoglobin level but took away Microalbuminuria and Fasting glycosuria from 
the questionnaire. Thereby, we tested the construct validity of the questionnaire that 
was formulated based on the literature review from different publications and book. 
4.2.1.2 Data collection procedures and tools 
Information was obtained by the principal investigator and working doctors of respective 
hospitals. It had a positive bearing on the reliability of the results in the way that all of 
them were well acquainted with the interpretation of the medical records from 
respective system. Training of the doctors on data collection procedure prior to the 
initiation of the study enabled them to follow the research objectives and get ensured 
that respondents had understood well the interview questions in the light of the 
objectives of the study. A preliminary survey on data collection tools and selection of 
hospitals helped to obtain complete and reliable data necessary for the study .There 
had been scope to recheck information from the medical records for many of the 
variables those were answered by the patients. This even helped to increase the 
reliability of the answers obtained from the patients. 
 4.2.2 Limitations of the study 
4.2.2.1 Confounding effects 
 In a case control study a researcher usually attempts to relate an exposure to an 
outcome but often measures an effect of third variable termed as confounding variable. 
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Pregnancy weight? 
In our study prepregnancy weight of these women was not recorded. Hence, we were 
also unable to measure rate of weight gain in pregnancy. Increased prepregnancy 
weight and weight gain in pregnancy might have an association on development of 
GDM (31). The risk of GDM in relatively overweight pregnant women in our study might 
have confounded by increased prepregnancy weight or pregnancy weight gain.  
Caesarean section? 
Increased caesarean section in this study might have taken place from other associated 
phenomenon in particular with a previous history of caesarean section in addition to 
GDM. We did not ask about history of previous c/s in our study .Thus it can be assumed 
that previous c/s could have been confounded to increased c/s in GDM pregnancy that 
was found as a significant predictor in outcome of GDM pregnancy. 
Hemoglobin level? 
Women with GDM were found nonanemic where as those without GDM have been 
noticed moderately anemic in pregnancy. As obesity and better socioeconomic status 
also contribute to good hemoglobin level we can refer both of these conditions which 
might have acted as confounding factors for better hemoglobin level in GDM 
pregnancy. 
In multivariate analysis mathematical modeling has measured a potential effect of one 
variable while simultaneously controlling for the effect of many other variables (46). 
Thus this study was able to show independent predictors for risk and outcome of GDM 
by controlling the confounding effects of some other variable. 
4.2.2.2 Biases 
Selection Bias 
We acknowledge that hospital population and nonrandom sampling procedure had put 
potential limitations on the selected samples. It is noteworthy that any hospital based 
study does have inherent selectiveness for its population group. According to statistical 
point of view all observational studies have built in bias but the challenge is to interpret 
how they have affected the outcome of the research. However in this case control study 
cases and controls were selected from same source of population. They represented a 
part of the general population coming to the hospital for pregnancy care.  
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Recall  and reporting bias 
Retrospective way of data collection in a case control study may pose some biases 
from recall problems. In the answer regarding positive family history of diabetes mellitus 
we encountered quite a lot of unknown answers in the control. Again, time of premature 
delivery in the previous pregnancies in some aspects was not recalled very correctly 
due to lack of previous pregnancy record.  It might have affirmed the fact that better 
recall of cases are common than non cases (48). 
Reporting bias can arise from the standpoint of local cultural context. When the 
investigator compared the history of prior abortion obtained by personal interview 
against central medical record they documented systematic underreporting of abortion 
in control. This might have arisen from the local cultural phenomenon where pregnant 
women feel ashamed of telling about their pregnancy.  
4.2.2.3 Internal validity of the findings 
This study represented the measurement based on the hospital record. We admit that 
this might have impact on internal validity. Beyond this assumption as BIRDEM is the 
best service provider for diabetes and MCHTI is also well recognized for obstetric care 
service the finding of the study possess reliable data. 
4.2.2.4 External validity for generalization 
In terms of generalizibility or external validity the findings of this study reflected the 
scenario of urban or semi urban pregnant women. The rural picture might have been 
different from this population group as some studies already were able to bring up 
different pattern of diabetes in between rural and urban area in Bangladesh on some 
aspects (14). Given that we believe the findings of the study can be inferred on the 
general population and is more likely to be externally valid for the pregnant women of 
Bangladesh.  
4.2.2.5 Reliability 
A face to face interview along with use of medical records has enabled the doctors to 
supplement information lacking in medical records from interview. In case of 
disagreement in medical record and interview an agreement was made and information 
was corrected. Moreover data procurement with direct inspection of mother and baby 
helped the doctors to verify their physical status and information collected. Still the 
retrospective way of data collection from two different health facility might have raised 
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question on its reproducibility .We agree that a prospective way of data collection would 
have powered more on reliability of findings. 
4.3 Discussion on the findings of the study 
4.3.1 Risk factors for GDM 
The results of this study have demonstrated that increasing maternal age is an 
independent risk factor for GDM in our obstetric population. Women aged 25 years or 
over were seen to have five times risk of GDM compared to women without GDM in this 
study. This was in line with the findings of another study done in the same institution 
where about 86.7 % of women with diabetic pregnancy were aged 25 or more than that 
(36). Our finding is also in accordance with the findings of a study conducted in rural 
Bangladesh where more than 50 % of the pregnant women with GDM diagnosed by 
WHO criteria had age range from 21- 30 years (2). In another hospital based study in 
Pakistan it has also been seen that about one half of the GDM women diagnosed by O 
Sullivan criteria lie in the range of 25-30 years (53). Our result on maternal age also 
supports the findings of other studies from India and Pakistan(40;54-57). Even though 
the GDM mothers were older than non-diabetic mothers, GDM women in this study are 
younger than the Caucasian mothers(58;59). This finding is an agreement with the 
result of other studies conducted in Indian subcontinent (55;57;60;61) . 
 In our study we didn’t find any women with GDM under the age of 20 but about 17% 
were seen from control group. Thereby it affirms more on that the risk of GDM is low in 
very younger or adolescent age. This finding bears significant importance when we see 
that still about 80% of women in Bangladesh marry in adolescence and 50% of them 
when they reach at 15 years (62). The average age of first child birth has also been 
seen very early (18 years) after marriage in the younger girls (61). However, the 
median age at marriage for the urban females is higher than rural females (58) which 
tend to impose increased risk of GDM in urban female population.  
This study showed strong association of pregnancy BMI with GDM. This finding was 
consistent with another study on diabetic pregnancy done in BIRDEM in 1999 (36). But 
the figure differed from a rural community based study in Bangladesh where mean BMI 
was found to be low in the women with GDM (2). Studies suggest that risk factors were 
similar for GDM and T2DM and include, among others, obesity, family history, and 
ethnic background. GDM was also associated with the metabolic syndrome (63). Some 
studies also demonstrated  that risk related to obesity for diabetes type 2 was higher in 
urban subject in comparison to rural (15;64). Therefore those facts are in agreement 
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with our study population who mostly belonged to urban area, had higher BMI and were 
increased risk of GDM. This is also with conformity with the findings of some studies 
conducted in India and Pakistan (55;65-68). 
 
We also observed in our study that pregnancy weight also differed significantly in GDM 
and control group while no significant difference was seen in the height of mothers. Our 
findings regarding pregnancy weight were in agreement with a previous study on 
diabetic pregnancy at BIRDEM (36). But the referred study was also able show 
significant association of height with diabetes in pregnancy. However, our finding is 
consistent with a study done over a Bengali population in India (69). No association of 
height with GDM was also revealed by another study on GDM in a rural community in 
Bangladesh despite the difference in the mean height (153 vs. 149 cm.) of women with 
GDM varied in these two studies (2). This dissimilarity might have arisen from selection 
of samples in respective study. 
 
We have seen in our study that women from middle and upper socioeconomic group 
possess risk of GDM. But previous studies done in BIRDEM found that pregnant 
women with diabetes were less educated than nondiabetic women (36). The reason in 
difference might have come from the fact that pregnant women without diabetes who 
are coming to BIRDEM for pregnancy care belonged to even wealthier group who can 
afford private health care service provided by BIRDEM. Another is that all the doctors, 
nurses and other stuffs of BIRDEM get free treatment from this hospital and therefore 
their rate of utilization is higher. However, prevalence of IGT and DM had been found 
higher in relatively wealthier people for both rural and urban area in Bangladesh (15). 
Another study done in Khagrachori district has found that diabetes type 2 is more 
prevalent in high income groups (70). So our finding is in line with the result of above 
mention studies. 
 
Based on our results it appears that educated women are at risk of GDM.By contrast 
another study in BIRDEM found less educated women to have diabetic pregnancy(36). 
This discrepancy might have arisen from the selection of samples. That study selected 
the controls from BIRDEM hospital which represented a rather wealthier and educated 
group of women. The explanation behind our finding might be that educated women 
tend to delay marriage and become pregnant at relatively older age. Despite the total 
fertility rate 3 per woman in Bangladesh the number of children ever born is   lower in 
the educated women who marry at older age (71). This fact fits well in our study as we 
see that higher prevalence of GDM was found in educated women.  
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The impact of socioeconomic factor on development of diabetes has been presented in 
different ways according to the scocio-cultural perspective. The scenario has been seen 
to present opposite picture in developed (31) and developing country .In developed 
country the poorer are seen to be obese and are likely to develop noncommunicable 
disease (72). On the other hand in developing country wealthier are at risk of 
noncommunicable disease. Our finding from this study has been seen to be in line with 
this postulation. 
We did not find any association of occupational status of women with GDM. Both in 
GDM and control group we noticed the predominance of housewife group who were not 
involved with any outdoor and income generation activities. It may be thought that the 
extent of physical activity done by housewives or women who had other type of job 
apart from being housewives doesn’t vary to a greater extent. Our study confirms that 
most of the women in our country are involved in house work. Women with a better 
socioeconomic condition usually get ‘paid helps’ in an urban structure at a very low cost 
which put them to reduced physical activities. In our culture there is no tradition of doing 
extra physical work or exercise apart from the daily job we do. So the occupational 
status of women represented the extent of daily physical activity performed by this 
group of women. Irrespective of their social class and level of education we may note 
that GDM doesn’t differ according to occupational status. 
We have observed a significant association of positive family history of diabetes with 
GDM. The finding of our study is an agreement with other studies in Bangladesh, India 
and other areas globally (33;34;57;60;61;72-75). We have also noticed many (25%) 
women without GDM with a positive family history of diabetes. It can be postulated from 
the findings that though these women are genetically predisposed to gestational 
diabetes, other controlling factors like increased physical activity, diet habit have 
regulated their glucose tolerance. Chan L.Y et al. reported that a positive family history 
is an isolated risk factor for the women over 30 years (33).It fits well with our control 
group as we saw many of them had positive family history of diabetes but no GDM. 
In univariate analysis we have seen that prevalence of GDM is affected by previous 
adverse obstetric outcome which included history of miscarriage, still birth and 
premature birth in our study. Our findings is in accordance with another population 
based study conducted in rural Bangladesh (2). Prevalence of GDM has been seen to 
increase steadily with a previous history of no, one, two or more miscarriage in 
Kashmiri women (57). Previous still birth rate was seen to be higher in diabetic 
pregnancy compare to women without diabetes (76). Similarly Naylor et al also found 
association of previous adverse obstetric outcome with GDM. However in multivariate 
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analysis we didn’t find a significant association. Our control group also had quite a large 
number of previous incidences of miscarriage and still birth. So it can be assumed that 
virtual absence of medical care facilities is responsible for the large numbers of fetal 
deaths due to complications of pregnancy, delivery, and environmental influences 
(77).The risk is high in Bangladesh context where more than 90% of delivery still takes 
place at home and most of which are not attended by skilled birth attended(78). 
We have observed that prevalence proportion of GDM increased with increase of 
gravidity from primi to multi. This affirms the result of a recent cross sectional study on 
GDM conducted in Indian hospital (55). There are many other studies in India. 
Pakistan, other Asian counties and other parts of the world which support this 
observation (32;35;55;57;65;75). Bangladeshi women have a longer reproductive age 
span and are of greater parity including grand multiparty. It is good to note that fertility 
rate has been found to have difference according to the place they belong to or live in 
Bangladesh. In multi-variate analysis we didn’t find any significant differences on the 
status of gravidity with GDM. One of the possible explanations for this is gravidity 
increases with increase of age. Increasing maternal age which is acting as a strong risk 
factor for GDM might have influenced the relationship of gravidity with GDM in 
descriptive analysis.  
Despite the observed risk of GDM in the women with a history of previous GDM it was 
not found to be associated with GDM in multivariate analysis. However all the women 
who had a history of previous GDM were also found to have GDM in the current 
pregnancy (79). Moreover we didn’t find anyone from the control group with a previous 
history of GDM. We are also aware that diagnosis of GDM in their previous pregnancy 
could be missed due to lack of diabetic screening during pregnancy. Women with a 
history of gestational diabetes mellitus (GDM) have a high risk of progression to type 2 
diabetes mellitus (T2DM). In women with impaired glucose tolerance, lifestyle 
modification or pharmacologic therapy may prevent or delay the onset of T2DM (63). 
One study has shown that Women with a history of gestational diabetes mellitus who 
have a BMI greater than 35 kg/m2, whose previous newborn was LGA, and who 
required insulin during their previous pregnancy are at increased risk for recurrence of 
gestational diabetes mellitus (80).So it can be postulated that by modification of life 





4.3.2 Pregnancy outcomes in GDM 
We have noticed lower prevalence of anemia in GDM population in comparison to the 
women without GDM in our study. In contrast, a previous study on diabetic pregnancy 
revealed higher prevalence of anemia in diabetic mother than those without diabetes 
.However that study included both gestational and pregestational diabetic women from 
BIRDEM and the findings on GDM were not analyzed separately. The elevated blood 
hemoglobin concentration in the GDM mothers can be ascribed to their increased body 
mass index. This finding is similar to several studies conducted by Lao TT et al. of 
China(81).  
Studies demostrated that the prevalence of anemia is more then 50% in pregnant 
women among the rural population  (82;83). Despite the high prevalence of anemia, 
severe cases of anemia were absent. This scenario was reflected in our control group. 
On the contrary, GDM mothers in our study possess nutritional adequacy. This finding 
matches well the fact GDM women usually represent wealthier part of the general 
population. 
One of our key findings was that the rate of hypertension in pregnancy was higher in 
GDM compared to the women without GDM. This is consistent with other reports  in 
Bangladesh (2;36). However we could not rule out whether hypertension was not 
existent before pregnancy. Several studies in India (16), Pakistan (47;84) and also in 
Saudi Arab (85) have reported increased risk for gestational hypertension and 
preeclampsia in pregnancies complicated by gestational diabetes(16). 16% of maternal 
death occurs due to eclampsia in Bangladesh (20;85). Preeclampsia was noticed to be 
associated with GDM in another study conducted in Bangladesh(86) which is an 
agreement with our findings. 
The overall incidence of caesarean section in the present study was significantly higher 
even after adjustment for confounders. Our finding supports the increased prevalence 
of caesarean section in GDM in one recent study done in Bangladesh (86). This has 
also similarity with the finding of some studies in Srilanka (60) and India (63) and 
Pakistan (45).  
The high rate of caesarean section in our study might be influenced by other factors 
extraneous to GDM in pregnancy (87). In GDM induction of labour is usually followed 
by caesarean section  (88). As there is increased chance of stillbirth in GDM despite 
modern management (76), the caution was taken on fetal monitoring. If there is any risk 
of fetus, immediate termination by caesarean section is the choice of intervention in 
order to ensure a safe delivery outcome. The presence of fasting hyperglycemia >5.8 
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mmol/l may be associated with an increase in the risk of intrauterine fetal death during 
the last 4-8 weeks of gestation (76). Perinatal complications are preventable with good 
glycemic control and early induction of labor, but at a cost of a higher Cesarean section 
rate (88). Mother’s psychological stress from death or bad outcome of previous infants 
and previous caesarean section were also seen to be responsible for increased 
caesarean delivery in GDM (87).  
We found that GDM was associated with an increased risk of preterm birth. This 
association was also independent of hypertension of pregnancy and birth weight of the 
newborn which might have triggered an earlier delivery. Our results are consistent with 
another study in India (63) and in Pakistan (45). Our study also revealed that 
prevalence of full term birth is very scarce in GDM. It must be acknowledged that this 
study didn’t draw any distinction between indicated preterm birth and spontaneous 
preterm birth. So the preterm delivery might have been affected by physician 
intervention by induced labor or caesarean delivery which has always been taking 
place as a safe guard for any type of risk in GDM in BIRDEM as well as other private 
hospitals in Bangladesh. 
In the present study, incidence of birth weight more than 3.5 kg in newborn babies born 
to mothers was significantly higher in the women with GDM than those without 
diabetes. The mean birth weight  in both the group are an agreement with another study 
done in BIRDEM (36) and in a public maternity hospital in Dhaka (89). Though we 
haven’t encountered more than one case of macrocosmic infant, our study observed 
the difference in distribution of birth weight between the groups. All of our women with 
GDM except one have been on treatment to control of their blood glucose level. Several 
studies were able to show that average control of glucose during the pregnancy period 
helped to restrict increasing progression of birth weight (22;44). 
The most commonly used definition of macrosomia is a birth weight equal to or 
exceeding 4000g. In our study the incidence was 0.08 % in GDM and 0.0% in Control 
group. The incidence is however far lower than other many published studies (>30%) 
conducted on GDM (54;90).Control of diabetes in most of the pregnancies either by diet 
or insulin might reduce the incidence of macrosomia in GDM. Studies proclaim that 
prophylactic insulin therapy will reduce the incidence of macrosomia among infants of 
GDM (91). This is also in conformity with a previous study done in BIRDEM hospital 
which included both pre GDM and GDM cases. It has been evidenced by some studies 
that babies born to Bangladesh women are also relatively smaller than that of 
Caucasian (56;92). 
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However we have found that women with GDM who were treated with insulin predict 
higher risk for increased birth weight of baby. One recent investigation  in India has 
explored that tight control of GDM  causes large for gestational age of the baby instead 
of reducing the birth weight (22).Another study done in New Zealand also demostrated 
that  women are more likely to have larger babies in spite of high use of insulin(93).One 
of the  explanation behind this result could be the effect of rebound hyperglycemias in 
insulin treatment (22). 
In our study, fetal abnormalities and complications such as intrauterine death, still birth, 
congenital anomalies were higher in GDM compared to normal pregnancies. But in 
bivariate analysis we haven’t found any difference between the foetal outcomes 
between these two groups .However, our findings are consistent with the result of 
several other studies which claim that perinatal mortality can be reduced with proper  
glycaemic control in pregnancy (22;40). Crother et al from a study in Australia also 
showed that severe perinatal complication were reduced through effective treatment in 
GDM (42). Ramachandran et al (44) found that infants of diabetic mother who had any 
type of diabetes before the onset of pregnancy , have higher mortality rate .GDM which 
mostly includes diabetes onset in pregnancy might have less  incidences of infant 
mortality. 
Our study encountered only two babies with congenital anomaly in GDM group while no 
one in the Non GDM group. But the statistical analysis did not show an association 
between GDM and congenital malformations. A larger number of sample would have 
been required to establish the relationship.However,one south Indian urban study found 
that congenital abnormalities in the fetus were more common among those, born of 
mothers with higher plasma glucose (9 versus 1.1%) (44). One study in Bangladesh 
has found incidence of congenital anomalies is about 2.3% (92).That study observed 
that GDM is a risk factor for  congenital anomaly in Bangladesh. This could also be due 
to the heterogeneity of the GDM; an entity usually detected relatively late in pregnancy 
but probably present since the first weeks of gestation when the teratogenic effect could 
occur. Occurrence of congenital anomaly might have been decreased because of 
earlier diagnosis of GDM and treatment in this study.  
Occurrence of low Apgar score didn’t vary statistically in our study between GDM and 
NonGDM.Some studies didn’t find association of low Apgar score at 5 min between 
treated GDM and a control group with normal pregnancy(94;95).However, another 
study suggested that early diagnosis of GDM predicts low Apgar score. But we didn’t 
find any statistical difference either by period of diagnosis or type of treatment. It can be 
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explained by the fact that early institution of tight metabolic control can reduce perinatal 
morbidity and mortality in GDM to normal level(96). 
We observed that hypoglycemia in neonates born to GDM mothers was significantly 
high in early diagnosed and insulin treated group. Several studies showed that 
maternal hyperglycemia is a contributing factor for neonatal hypoglycemia(37;93).In 
addition women treated with insulin who usually have higher blood glucose also predict  
risk of hypoglycemia in newborn(93).In accordance  with these findings ,early 
diagnosed GDM mothers in our study ,most of who were treated with insulin ,possess 
higher risk for  hypoglycemia in their newborn.  
The mean gestational week of diagnosis of GDM in our study was lower (23 weeks) 
than recommended time screening for GDM. Moreover about 43% of the women were 
diagnosed early. Meyer WJ et al.  also found 40% of GDM detected in early pregnancy 
screening protocol(21). This matches well with reports  which claim that 40%-60% of 
gestational diabetes can be detected in early pregnancy(97) .It is likely that most of 
these women were Type 2 pregestational diabetes who were diagnosed during 
pregnancy more than having actual pregnancy-induced glucose intolerance. 
Nevertheless changes in carbohydrate homeostasis can start as early as 6 weeks’ 
gestation.Consecuently they could have pregnancy induced glucose tolerance. In both 
situations it has been glucose intolerance found in early pregnancy implies a higher 
risk(98). They predict increased incidence of obstetric (4) and neonatal complications 
which also fits with our finding. Therefore early diagnosis of them is needed in order to 
control adverse pregnancy outcome(97). 
Our study revealed that women diagnosed early in pregnancy had higher risk for being 
treated with insulin. This finding is in conformity with a study conducted by Barahona 
MJ et al (99).It can be explained by the hypothesis that these women had increased 
insulin resistance for which most of them need insulin to control their hyperglycaemia.In 
addition they are then at increased risk of getting Type 2 diabetes  early or at younger 
age(4). 
Hypertension in pregnancy was significantly associated with the women diagnosed 
early in pregnancy in our study when compared with the controls. The increased rate of 
hypertension in the early diagnosed GDM it is probable that many of these women had 
undiagnosed type 2 diabetes, which is known to be linked with hypertension. Our 
finding is an agreement with another study which demonstrated that despite appropriate 
obstetric management, women with early onset gestational diabetes increases the risks 
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In summary we conclude that commonly recognized risk factors for GDM are 
prevalent in the study population. The results suggest that urban and suburban 
woman with increasing age or who has a family history of diabetes or increased 
BMI was at higher risk for GDM. 
  
Onset of GDM can be as early as before 20 weeks of gestation in quite a larger 
portion of women with GDM .Women diagnosed with GDM at an early pregnancy 
were more likely to be treated with insulin.  
 
Hypertension, caesarean section and preterm delivery were more prevalent in the 
women with GDM. The occurrence of macrosomia was very low in the treated 
cases of GDM but the likelihood of birth weight more than 3.5 kg was rather more 
in them than the women without diabetes. 
 
Maternal and neonatal complications did not vary among those either treated with 
insulin or diet .Events of hypoglycemia was more prevalent in the women who 
were diagnosed early or treated with insulin. 
 
 Women diagnosed as GDM early in pregnancy predict higher risk of having 
hypertension in pregnancy than those with no GDM .Over representation of birth 
weight more than 3.5 kg was noted for the women treated with insulin in GDM. 
 
Selective screening for GDM for all the pregnant women of Bangladesh bears 
significant importance as women with GDM are at high risk of pregnancy and 
delivery outcome. Therefore we made the following recommendations based on 



















 5.2 Recommendations 
 
1. Diagnosis and treatment of GDM are to be put into national antenatal check up 
program so that 5-8% of the risk pregnancy from GDM can be identified .Thus 
measures are to be taken to avoid preventable consequence to the mother and 
fetus/newborn. 
 
2. Pregnant women at their first antenatal check up needs to be checked for 
gestational diabetes.  
 
3. As quite a large number of women were diagnosed early in pregnancy screening 
of GDM needs to be carried out in early trimester. We suggest that this subgroup 
of women with gestational diabetes is to be promptly identified. Their situation 
can be considered equivalent to that of women with pregestational diabetes 
mellitus and managed as such. 
 
4.  A standard treatment guideline including referral instruction is to be prepared 
and available to the health professional so that they can identify GDM as well as 
make a birth plan for GDM in pregnancy. 
. 
5. Particular attention needs to be given to the women who are diagnosed early in 
pregnancy as they are more likely to develop hypertension in pregnancy, need 
insulin treatment and their newborn are prone to develop hypoglycemia. In this 
regard all health personnel concerned with conducting diabetic delivery are to be 
trained off on management of hypoglycemia in newborn  to prevent grave and 
undesired effect of hypoglycemia in newborn. 
 
6. Women who are treated with insulin need particular attention as they may lead to 
birth of relatively larger baby if their blood glucose was not controlled in a proper 
way. 
 
7. Women with GDM should be followed after delivery in order to monitor 















 5.3    Further research implication 
 
1. Our study could not focus on the association of fasting glycosuria, problem of 
fertility, history of preterm birth or macrosomia or previous caesarean section 
and rate of miscarriage or other fatalities due to limitations time and resources. 
An additional study needs to be taken up to measure the association of all these 
conditions related to GDM in Bangladesh. 
 
2.  We would also suggest for conducting a hospital based surveillance study for risk 
factors and pregnancy associated complications of GDM in line with diabetes 
type 2 under the ongoing surveillance of noncommunicatable diseases in 
Bangladesh. 
 
3. Women with GDM should be followed up in a prospective study in order to look 
at the risk of DMT2 in them. The women identified as GDM are to be put under 
an intervention study so that what actually happens to them in the future can be 
traced out. Thus a further interventional prospective study on this issue would 
have long term implication of GDM on the promotion of health and reduction of 
diseases burden. 
 
4.  A prospective study to measure the association of GDM and varying grade of 
hypertension in pregnancy demands attention in the increased prevalence of 
diabetes type 2, preeclampsia and hypertension in the women of Bangladesh. 
 
5. We also suggest carrying out a study to further assess the mode of delivery in 
GDM. As our study found a huge number of caesarean section in GDM 
pregnancy, this made us to be critical to think on the indication of caesarean 
section as well as effective birth plan for the GDM cases in Bangladesh. 
 
6. We also recommend carrying out a study with the children born to mothers with 
GDM to look at the pattern of illness and risk of diabetes or coronary heart 
diseases in them. 
7. Early diagnosed GDM were seen as a high risk subgroup among GDM.Further 
studies is also suggested to clarify outcome of pregnancy according to period of 
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 Appendix - 1 (Questionnaire)  
 
 
Date of interview: …………………………………………………………………………………………………………………………………………. 
Hospital 
      BIRDEM: ………………………………….. 
      Others: ………………………………………. 
Place of Interview: ………………………………………………………………………….. 
Interview taken by: …………………………………………………………………………… 





  Record Interview Clinical 
investigation
Age (in years)    
Ht (m)    
Wt (kg)    




   
House wife    Main occupation 
others    
Monthly expenditure Local currency 
(TK) 
















Contact Address: ……………………………………………………………………………………………………………………………………. 




Family and Obstetric History 
 
     
Yes    
No    
Diabetes in the 
family(first, second and 
third degree relation) 
 
Unknown    
EDD     
LMP     
Yes    
No    
Unknown    
Previous history of 
GDM 
Not applicable    
Miscarriage    
Still born    
Premature 
Birth 
   
Gravida    
Previous bad obstetric 
history 
Not applicable    
Weeks of 
gestation 
   
Not diagnosed    
Time of diagnonsis of 
GDM 
Not applicable    
Diet and 
exercise 
   
Insulin    
Main treatment til 
delivery 
No treatment    
Blood sugar level Mmol/L    
On diagnosis 
Range of blood 
glucose level during 
pregnancy 
Mmol/l    
RBS During Pregnancy     
RBS within 24 hours 
before delivery 
    
yes    Hypertension 
No    









<32 wks    
32-36 wks    
Gestation  at delivery 
 
37-39 wks     
Full term    
Post dated    
 
 
   Post term 
   Normal 
vaginal 
Mode of delivery 
Assisted    
 
 
    Caesarean 
   Live birth 
Live birth with 
injury 




Live birth with 
birth defect 
    
 
Still born     




     
   Birth weight (gm) 
   APGAR at 1 min  


























Appendix – 2 (Antenatal Card-shown partly, BIRDEM) 
 














Appendix – 2 (Antenatal Card -shown partly, BIRDEM) 
 













































Appendix – 3 (Antenatal Card-shown partly, MCHTI) 
 
 





































Appendix – 3 (Antenatal Card-shown partly, MCHTI) 
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